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The anterior cruciate ligament (ACL) is the most frequently injured knee ligament.  
Because of its low healing capacity, the current standard of treatment is surgical ACL 
reconstruction.  However, follow-up studies 10 years or more after surgery have shown that 
patients frequently experience long-term complications, including the early development of 
osteoarthritis.  For this reason, scientists and clinicians have explored alternative treatment 
methods.  With the advent of functional tissue engineering, there has been renewed interest in 
regenerating an injured ACL using biological augmentation.  Still, due to the slow process of 
ACL healing, mechanical augmentation is also needed to restore stability to the knee 
immediately after surgery, as well as to load the ACL throughout the healing process. 
The purpose of this dissertation was to develop and test a bioresorbable magnesium (Mg) 
device for mechanical augmentation of a transected ACL in a goat model.  First, a ring-shaped 
device was designed based on the geometry of the goat ACL, and evaluated using a parametric 
finite element analysis.  Then, a robotic/universal force-moment sensor testing system was used 
to measure the joint stability and in-situ forces in the ACL after repair of the ACL in cadaveric 
goat stifle joints using the Mg ring (“Mg ring repair”).  Under externally applied loads simulating 
those used in clinical examinations, Mg ring repair could restore joint stability and in-situ forces 
in the ACL close to normal levels.  With these positive findings, in vitro cytocompatibility 
testing was performed by culturing goat ACL fibroblasts with Mg degradation products.  Results 
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on cell proliferation and collagen production suggested that the presence of Mg neither impeded 
nor enhanced the healing process.  Finally, the Mg ring was used to repair a surgically transected 
ACL in skeletally mature goats alongside biological augmentation using an extracellular matrix 
(ECM) sheet and hydrogel.  In this in vivo study, by 6 weeks post-operatively, neo-tissue had 
begun to fill in the gap between the transected ends of the ACL.  By 12 weeks, the ACL was 
found to have healed and the continuous neo-tissue was composed of aligned collagen fibers, but 
without hypertrophy.  Biomechanically, the structural properties of the healing femur-ACL-tibia 
complex were improved compared to ECM treatment alone.  
  With the results from this dissertation, the advantages of using combined biological and 
mechanical augmentation to improve healing of a transected ACL have been demonstrated.  
Building off these findings, future studies can be performed to further enhance ACL healing, as 
well as extend the application to the healing of other injured ligaments and tendons.  It is our 
hope that in the future, such an approach could be used clinically to improve short and long-term 
patient outcomes after orthopaedic surgery. 
vi 
TABLE OF CONTENTS 
PREFACE ................................................................................................................................. XVI 
1.0 BACKGROUND .................................................................................................................. 1 
1.1 ACL ANATOMY AND FUNCTION ......................................................................... 1 
1.2 ACL INJURIES ........................................................................................................... 4 
1.2.1 Incidence and consequence of ACL injuries .................................................. 4 
1.2.2 Clinical treatments ........................................................................................... 5 
1.2.2.1 Conservative treatments ...................................................................... 5 
1.2.2.2 Surgical repair ...................................................................................... 6 
1.2.2.3 ACL reconstruction .............................................................................. 7 
1.2.2.4 Rationale for a new treatment option ................................................. 8 
1.3 LIGAMENT HEALING ........................................................................................... 10 
1.3.1 MCL healing ................................................................................................... 10 
1.3.2 Functional tissue engineering approaches ................................................... 11 
1.3.2.1 Growth factors .................................................................................... 12 
1.3.2.2 Stem cells ............................................................................................. 13 
1.3.2.3 Extracellular matrix scaffolds ........................................................... 13 
1.3.3 Challenges for ACL healing .......................................................................... 16 
1.3.4 Current and new approaches to ACL healing ............................................. 17 
vii 
1.3.4.1 Biological augmentation ..................................................................... 18 
1.3.4.2 Mechanical augmentation .................................................................. 19 
1.3.4.3 Combined biological and mechanical augmentation ....................... 20 
1.4 MAGNESIUM AS A BIOMATERIAL FOR ORTHOPAEDIC 
APPLICATIONS ....................................................................................................... 20 
1.4.1 Background on orthopaedic biomaterials .................................................... 20 
1.4.2 Biocompatibility ............................................................................................. 23 
1.4.3 Historical use of Mg for orthopaedic implants ............................................ 24 
1.4.4 Recent advances in Mg materials ................................................................. 24 
1.4.4.1 Alloying and mechanical properties.................................................. 25 
1.4.4.2 Corrosion behavior ............................................................................. 26 
1.4.4.3 In vitro and in vivo cytocompatibility and healing potential ........... 27 
1.4.5 Rationale for use of Mg for ACL healing..................................................... 30 
2.0 OBJECTIVES .................................................................................................................... 32 
2.1 OVERALL GOALS .................................................................................................. 32 
2.2 SPECIFIC AIMS ....................................................................................................... 32 
3.0 DESIGN AND FINITE ELEMENT ANALYSIS ........................................................... 37 
3.1 GEOMETRY ............................................................................................................. 37 
3.2 DEVICE DESIGN AND SUTURE TECHNIQUE ................................................. 38 
3.3 FINITE ELEMENT ANALYSIS ............................................................................. 43 
3.3.1 Background ..................................................................................................... 43 
3.3.2 Model development ........................................................................................ 44 
3.3.3 Finite element analysis results....................................................................... 51 
4.0 IN VITRO ROBOTIC/UFS EVALUATION OF MG RING REPAIR OF THE ACL 57 
viii 
4.1 EXPERIMENTAL DESIGN .................................................................................... 57 
4.2 ROBOTIC TESTING PROCEDURE ..................................................................... 58 
4.3 RESULTS ................................................................................................................... 61 
5.0 COMBINED BIOLOGICAL AND MECHANICAL AUGMENTATION
         FOR ACL HEALING ........................................................................................................ 67 
5.1 IN VITRO CELL CULTURE STUDIES ................................................................. 67 
5.1.1 Background ..................................................................................................... 67 
5.1.2 Experimental Methods .................................................................................. 70 
5.1.2.1 Preparation of extracts from Mg materials ...................................... 70 
5.1.2.2 Cell culture methods ........................................................................... 71 
5.1.2.3 Cell proliferation assay ....................................................................... 71 
5.1.2.4 Collagen production assay ................................................................. 73 
5.1.3 Results ............................................................................................................. 74 
5.2 IN VIVO ACL HEALING STUDY .......................................................................... 80 
5.2.1 Experimental Methods .................................................................................. 80 
5.2.1.1 Animal model ...................................................................................... 80 
5.2.1.2 Preparation of Mg ring devices ......................................................... 80 
5.2.1.3 Preparation of ECM bioscaffolds ...................................................... 82 
5.2.1.4 Surgical procedure .............................................................................. 83 
5.2.1.5 Post-operative care ............................................................................. 84 
5.2.1.6 Gross morphology ............................................................................... 85 
5.2.1.7 Histological evaluation ....................................................................... 86 
5.2.1.8 In vivo degradation of the Mg ring .................................................... 86 
5.2.1.9 Analysis of synovial fluid.................................................................... 88 
ix 
5.2.1.10 Biomechanical testing ....................................................................... 89 
5.2.1.11 Data analysis...................................................................................... 92 
5.2.2 Results ............................................................................................................. 93 
5.2.2.1 Gross morphology of the healing ACL ............................................. 93 
5.2.2.2 Histological evaluation ....................................................................... 96 
5.2.2.3 Degradation of the Mg ring ............................................................. 100 
5.2.2.4 Cytology and total protein content of synovial fluid ..................... 102 
5.2.2.5 Joint stability and in-situ forces ...................................................... 103 
5.2.2.6 Tensile properties .............................................................................. 108 
5.2.2.7 Comparison to ECM treatment alone ............................................. 109 
6.0 DISCUSSION AND FUTURE DIRECTIONS .............................................................. 114 
6.1 DISCUSSION OF THE MG RING DESIGN ....................................................... 115 
6.2 IN VITRO ROBOTIC TESTING ........................................................................... 117 
6.3 IMPACT OF THE IN VITRO AND IN VIVO EVALUATION OF THE MG 
         RING FOR ACL HEALING .................................................................................. 118 
6.4 IMPACT AND IMPLICATION FOR TISSUE ENGINEERING AND 
         REGENERATIVE MEDICINE ............................................................................. 123 
6.5 LIMITATIONS ........................................................................................................ 124 
6.6 FUTURE DIRECTIONS ........................................................................................ 127 
BIBLIOGRAPHY ..................................................................................................................... 132 
x 
 LIST OF TABLES 
Table 1: Dimensional parameters estimated from geometry of a goat ACL ................................ 38 
Table 2: Designs of the Mg ring used in the parametric finite element analysis .......................... 45 
Table 3: Mechanical properties of Mg alloys for finite element model ....................................... 45 
Table 4: Resulting Von Mises stress from the parametric finite element analysis of the Mg ring 
(* indicates a value that has exceeded the yield stress; 
# 
 indicates a value that has
exceeded the failure stress) ............................................................................................... 53 
Table 5: Experimental protocol and data obtained using the robotic/UFS testing system under a 
67-N anterior tibial load without (I-III.A) and with (I-III.B) 100 N axial compression ... 59
Table 6: Anterior tibial translation (mean ± SD) of the goat stifle joints tested at 30°, 60°, and 
90° of flexion in response to: (A) a 67-N anterior tibial load and (B) a 67-N anterior tibial 
load + 100 N axial compression........................................................................................ 63 
Table 7: In-situ forces in N (mean ± SD) in the: (I) ACL and (II) medial meniscus of the goat 
stifle joints at 30°, 60°, and 90° of flexion in response to (A) a 67-N anterior tibial load 
and (B) a 67-N anterior tibial load with 100 N axial compression ................................... 63 
Table 8: Initial (left) and final (right) pH values of Mg extracts .................................................. 74 
Table 9: Lameness scoring scale................................................................................................... 84 
Table 10: Qualitative scale describing degradation of the Mg ring .............................................. 86 
Table 11: Scores representing the degradation of the Mg ring at 12 weeks of healing ................ 96 
Table 12: Anterior-posterior tibial translation (A) and in-situ forces in the ACL (B) of the sham-
operated and Mg ring-repaired goat stifle joints at 30°, 60°, and 90° of joint flexion 
(*indicates a statistically significant different compared to sham-operated controls; P ≤ 
0.05) ................................................................................................................................ 105 
xi 
Table 13: Structural properties of the healing and sham-operated FATCs (*indicates a 
statistically significant different compared to sham-operated controls; P ≤ 0.05) ......... 108 
xii 
LIST OF FIGURES 
Figure 1: A schematic diagram of the human knee joint, illustrating the ACL as well as 
surrounding structures ......................................................................................................... 2 
Figure 2: A representative load-elongation curve of a goat femur-ACL-tibia complex ................. 3 
Figure 3: Histogram showing the number of publications each year on research of Mg and its 
alloys and stainless steel as biomaterials .......................................................................... 22 
Figure 4: Gradual shift in the contribution to ACL function over time of a Mg device versus the 
healing tissue ..................................................................................................................... 31 
Figure 5: (A) Geometry and working length of the goat ACL, (B) Cross-sectional shape as 
measured by a laser micrometer system ........................................................................... 38 
Figure 6: Prototypes of the Mg ring .............................................................................................. 39 
Figure 7: Procedural details for Mg ring repair, depicting attachment of repair and fixation 
sutures to the ACL (A), followed by attachment and fixation of the ring (B) .................. 42 
Figure 8: Illustration of 3 predicted types of in-situ loading of the Mg ring ................................ 46 
Figure 9: Initial rendering (A) and final 3-D model (B) of the goat stifle joint ........................... 47 
Figure 10: Schematic diagram illustrating that the Mg ring could not be driven into the femoral 
intercondylar notch by axial compression ........................................................................ 48 
Figure 11: The Mg ring in Ansys software modeled with a cone of the same inner diameter to 
constrain the device from rigid body motion under loading ............................................. 49 
Figure 12: Directions of loading in the finite element model simulating tension from fixation 
sutures with a  40 N tensile load (left) and 20 N load normal to the surface of the Mg ring 
(right) ................................................................................................................................ 50 
Figure 13: Medial and lateral loads applied to the Mg ring (A= anterior, P= posterior) .............. 51 
xiii 
Figure 14: Results on the Von Mises stress distributions for the parametric finite element 
analysis of the Mg ring ..................................................................................................... 54 
Figure 15: Photograph of the testing set-up for Specific Aim 2, depicting the cadaveric goat stifle 
joint (A), universal force-moment sensor (B), and robotic manipulator (C) .................... 60 
Figure 16: Normalized anterior tibial translation of the Mg ring-repaired and suture-repaired goat 
stifle joints at 30°, 60°, and 90° of flexion under (A) a 67-N anterior tibial load and (B) a 
67-N anterior tibial load with 100 N axial compression ................................................... 65 
Figure 17: Normalized in-situ forces in (I) the ACL and (II) the medial meniscus in the Mg ring-
repaired and suture-repaired goat stifle joints at 30°, 60°, and 90° of flexion under (A) a 
67-N anterior tibial load and (B) a 67-N anterior tibial load with 100 N axial compression
........................................................................................................................................... 66 
Figure 18: Mg materials selected for in vitro testing in Specific Aim 3.1 .................................... 68 
Figure 19: Osmolality (mOsm/kg) of Mg extract dilutions .......................................................... 75 
Figure 20: Resulting proliferation (% of control) of goat ACL fibroblasts after 3 days of culture 
with extracts prepared from single crystal Mg (mean ± SD) ............................................ 76 
Figure 21: Resulting proliferation (% of control) of goat ACL fibroblasts after 3 days of culture 
with extracts prepared from Mg materials (mean ± SD) .................................................. 77 
Figure 22: Soluble collagen produced (% of controls) by goat ACL fibroblasts after 3 days of 
culture with extracts prepared from single crystal Mg (mean ± SD)  (* indicates a 
statistically significant difference) .................................................................................... 78 
Figure 23: Soluble collagen produced (% of control) by goat ACL fibroblasts after 3 days of 
culture with extracts prepared from Mg materials (mean ± SD)  (* indicates a statistically 
significant difference, # indicates statistical difference from all other materials) ............ 79 
Figure 24: A single crystal of Mg produced using the Bridgman technique (courtesy of Dr. V. 
Shanov) ............................................................................................................................. 81 
Figure 25: Single crystal Mg rings before (left) and after coating via micro-arc oxidation (right)
........................................................................................................................................... 82 
Figure 26: Cross-sectional slice of the degrading Mg ring from micro-CT scan (A), with 
manually-selected region of interest surrounding the Mg ring depicted in black and intact 
Mg depicted in white (B) .................................................................................................. 88 
Figure 27: A schematic illustrating a joint being tested on the robotic/UFS testing system at 
preselected angles of joint flexion, providing 5-DOF joint kinematics (AP – anterior-
xiv 
posterior, FE – flexion-extension, IE – internal-external, ML – medial-lateral, PD – 
proximal-distal, VV – varus-valgus)................................................................................. 90 
Figure 28: The FATC mounted on the materials testing machine for uniaxial tensile testing ..... 92 
Figure 29: Gross morphology of the healing ACL at 6 weeks ..................................................... 94 
Figure 30: Gross morphology of the sham-operated ACL (A) and Mg ring-repaired ACL (B) .. 95 
Figure 31: Cross-sectional area and shape of the sham-operated and healing ACL .................... 95 
Figure 32: Histology of the sham-operated ACL, depicting longitudinally-aligned collagen 
bundles (A) and normal synovium (B) (L – ligament) ..................................................... 97 
Figure 33: Histological section of the healing FATC at 6 weeks of healing using H&E staining 
(T= tibia, A= ACL, P= PCL, F= femur) ........................................................................... 98 
Figure 34: Histological image of the Mg ring–repaired ACL (A), pitting corrosion lined with 
hyalinized collagen (B), small degrading fragments of the Mg ring (C), and lack of 
normal synovium around ACL tissue adhered to inner surface of the Mg ring (D) (G= 
granulation tissue, M= Mg ring, C= collagen) .................................................................. 99 
Figure 35: Histological section of the healing FATC at 12 weeks of healing using H&E staining 
(T= tibia, A= ACL, F= femur; arrow indicates Mg fragment) ....................................... 100 
Figure 36: 3D rendering of the degrading Mg ring at 6 weeks of healing in the goat stifle joint 
with femoral and tibial bone blocks ................................................................................ 101 
Figure 37: Total protein content in synovial fluid from sham-operated and healing goat stifle 
joints at 12 weeks of healing (P < 0.05) ......................................................................... 103 
Figure 38: Average curves for the APTT in the sham-operated and Mg ring-repaired joints at 60° 
of stifle joint flexion under a 67-N anterior-posterior tibial load (mean ± standard error)
......................................................................................................................................... 104 
Figure 39: In-situ forces in the MCL, soft tissue, medial meniscus, lateral meniscus, bony 
contact, and ACL in the sham-operated and Mg ring-repaired goat stifle joints at 30° (A), 
60° (B), and 90° (C) of joint flexion ............................................................................... 107 
Figure 40: Gross morphology of the healing ACL with ECM treatment + Mg ring repair (A) and 
ECM treatment alone (B) ................................................................................................ 109 
Figure 41: Cross-sectional area (% of control) of the ECM-treated ACL and ECM + Mg ring-
repaired ACL .................................................................................................................. 110 
xv 
Figure 42: Normalized APTT (A) and in-situ forces in the ACL (B) in the healing goat stifle 
joints with ECM-treated or ECM + Mg ring-repaired ACLs ......................................... 111 
Figure 43: Normalized stiffness (A) and ultimate load (B) of the femur-ACL-tibia complex with 
the ECM-treated and ECM + Mg ring-repaired ACL ..................................................... 113 
Figure 44: Photographs illustrating sliding of the femoral fixation sutures at 12 weeks of healing 
in 2 specimen, showing the gap between the Endobutton and femur before (left) and after 
applying tension (right) ................................................................................................... 123 
Figure 45: Schematic diagram for further development of a combined biological and mechanical 
augmentation strategy to heal an injured ACL ............................................................... 129 
  xvi 
PREFACE 
 
When I moved across the country and entered the Bioengineering Ph.D. program at Pitt in 2010, 
nothing could have prepared me for the challenges, obstacles, and eventual growth that lay 
ahead.  However, although this process has been a transformative one for me, it would never 
have been possible without the collaboration, help, and support of many others.  I would like to 
acknowledge these individuals for their contributions to this work.   
I would first like to thank my mentor, Dr. Savio L-Y. Woo, for shaping me as a scientist, 
researcher, and person.  You have helped me to become a confident and capable researcher, and I 
am forever grateful for that.  You taught me to respect and learn from the past, to always ask 
questions, and to strive to always be different and better.  It is because of you that I now “think 
like a contrarian.” 
Of course, this work would not have been possible without the help and support of the 
rest of the MSRC.  Thank you to Diann DeCenzo for keeping the MSRC in order and for also 
being a friend and the best lunch companion I could ask for.  To Dr. Kwang Kim, thank you for 
being my “big brother” in lab and guiding me until I could stand on my own two feet.  To 
Jonquil Flowers, thank you for your help in completing this work, as well as for being my 
teammate.  Thank you to our orthopaedic surgeon residents, Matteo Tei, Andrea Speziali, 
Norihiro Sasaki, and Antonio Pastrone, for your tireless and enthusiastic work to make the vision 
  xvii 
of the “Mg ring” a reality.  Finally, thank you to the numerous undergraduate students who have 
dedicated their time and effort into the MSRC and made the lab a livelier place.  
I would also like to thank the numerous collaborators who contributed significantly to 
this thesis.  Throughout my time in the Ph.D. program, I have had the excellent opportunity to 
work with top-notch researchers and clinicians from all over the world, and they have greatly 
impacted and shaped this work. To Drs. Vesselin Shanov, Yeoheung Yun, Prashant Kumta, 
Stephen Badylak, Kostas Verdelis, and Steven Abramowitch, Alejandro Almarza, as well as 
many of your students, I am indebted to you for your help and collaboration on this work.  To 
Dr. Patrick McMahon, thank you for your feedback and guidance on the clinical side of this 
project.   
Lastly, I thank my friends and family.  I am so happy to now have networks of friends on 
the east and west coasts, both of which have supported me along this journey.  To my brothers, 
Eric and Ryan, thank you for making my life more colorful and inspiring me with your own 
success (and encouraging my competitive nature to try to one-up you!).  To my parents, 
Raymond and Charlene, I am truly grateful for your endless support and love.  From helping me 
with elementary school science projects to aiding me with my algebra and calculus homework to 
encouraging me to take a physiology class, you fostered in me a love of math and science that 
has led me to where I am today.  Thank you. 
 
 
 
1 
1.0 BACKGROUND 
1.1 ACL ANATOMY AND FUNCTION 
The anterior cruciate ligament, or ACL, is the most important stabilizer in the knee (Figure 1) 
39
.
Its function to restrain excessive anterior tibial translation 
136, 179
, and it also plays a role in
controlling internal-external 
112
 and varus-valgus rotations 
76, 111
.  Originating at the 
posterolateral intercondylar notch of the femur, it becomes larger in cross-section as it 
approaches the anterior intercondylar eminentia of the tibia 
55
.  The cross-sectional shape of the
ACL is irregular and varies with knee flexion, muscular activity, and external loads.  Based on 
the tensioning patterns of the ACL during passive flexion-extension, it has been considered that 
the ACL has two distinct fiber bundles: the anteromedial (AM) bundle and posterolateral (PL) 
bundle 
83
.  The AM bundle is important for the restraint of anterior tibial translation 
136, 199
, and
the PL bundle is important for restraint of rotatory motion 
179
.
The ACL is 65-70% water by weight, with 70-80% of the dry weight composed of Type I 
collagen organized into longitudinally-aligned fibrils with a crimped pattern 
189
.  The unique
crimp pattern serves a protective function, as it permits for some tissue deformation in tension 
without damage as the crimped fibrils straighten and are recruited gradually.  As these fibrils are 
aligned along the axis of loading, the ACL is also well-equipped to withstand larger tensile 
loads. This allows the ACL to guide joint motion under low loads during normal activities, as 
2 
well as to limit excessive motion and prevent injury under greater loading.  Under uniaxial 
tensile testing of the femur-ACL-tibia complex (FATC), a nonlinear load-elongation curve is 
produced, whereby there is first a toe region of low stiffness as the collagen fibrils of the ACL 
straighten, followed by a linear region of higher stiffness as the fibers are stretched.  Finally, the 
ultimate load is reached, after which failure of the FATC occurs  (Figure 2) 
226
.
Figure 1: A schematic diagram of the human knee joint, illustrating the ACL as well as surrounding 
structures 
3 
Figure 2: A representative load-elongation curve of a goat femur-ACL-tibia complex 
Biochemically, the ACL also contains glycosaminoglycans, proteoglycans, elastin, and 
cells.  Nutrition is mostly provided by the middle genicular artery, with branches extending along 
the length of the ACL beneath its protective synovial layer, as well as some endoligamentous 
vessels 
55
.  Innervation of the ACL is by branches of the tibial nerve and consists of nerve fibers
with vasomotor functions as well as mechanoreceptors, including Ruffini and Pacini receptors 
19
.
These provide a proprioceptive ability that serves to protect and prevent injury to the ACL 
28, 90
.
4 
1.2 ACL INJURIES 
1.2.1 Incidence and consequence of ACL injuries 
The ACL is the most frequently-injured ligament in the knee, with an estimated 200,000 injuries 
per year in the United States 
29, 84
.  Most occur during sports-related activities through noncontact
mechanisms that involve cutting, pivoting, or landing occurs with the knee near full extension 
84
.
However, unlike extra-articular ligaments such as the medial collateral ligament (MCL), which 
heals spontaneously after injury 
100
, the intra-articular ACL has been shown to typically exhibit a
poor healing response following injury, even in the case of a partial tear 
36
.  The reasons for this
limited healing capacity will be discussed in Section 1.3.3. 
The loss of this key stabilizer can lead to many serious consequences.  ACL deficiency 
results in immediate knee instability, primarily due to an increase in anterior tibial translation 
and internal rotation of the tibia that could result in persistent pain or buckling of the knee.  With 
such a change in the knee kinematics, other supporting structures in the knee, including the 
medial meniscus, MCL, and the posterolateral structures would be subjected to large amounts of 
compensatory loading, increasing their risk of injury 
12, 110, 180
.  These complications can have a
significant effect on a patient’s knee-related quality of life, particularly in the case of active 
patients.  Many patients are forced to modify their activity level, and many athletes are not able 
to return to their previous sport 
50
.
In addition to the biomechanical changes that occur with ACL injury, biochemical 
changes related to cartilage degeneration have also been observed, even just one year after injury 
40, 156, 175
.  As a result, long-term consequences of ACL injury can be catastrophic, as these 
degenerative changes in the knee can lead to the early onset of osteoarthritis 
11
.  A recent meta-
5 
analysis based on a number of long-term follow-up studies of ACL reconstruction has shown a 
significant risk for developing radiographic osteoarthritis.   Compared to contralateral knees, this 
risk quadrupled at 10 years after surgery, regardless of whether the patient received surgical 
ACL reconstruction or underwent conservative treatment 
8
.  The numbers are even more 
staggering for athletes, with one study reporting radiographic osteoarthritis in 78% of young 
male soccer players 14 years after ACL injury 
207
.  Particularly in the case of younger patients
with many years of knee function ahead, these degenerative effects could eventually lead to the 
need for extreme measures such as a total joint replacement. 
1.2.2 Clinical treatments 
The major aims of clinical treatments for ACL injury are to restore ACL function and knee 
stability to manage short-term symptoms, with the hope of precluding the development of 
osteoarthritis.  These treatments have consisted of conservative management using rehabilitation 
programs, as well as surgical techniques. 
1.2.2.1 Conservative treatments 
Approximately one-third of patients today elect to undergo non-operative, conservative treatment 
for their ACL injury. Typically, conservative treatment consists of rehabilitation programs 
designed to strengthen the hamstrings and quadriceps muscles, restore balance and knee range of 
motion, in addition to recommended bracing 
82
.
The use of conservative treatment following ACL injury has been controversial.  
Although some have reported that the modification of physical activity and rehabilitation to 
6 
restore neuromuscular function led to good long-term knee function 
46, 125
, many others have
found less favorable results.  Anterior and rotatory instability have been reported in a large 
number of patients, as well as subsequent injury to other structures in the knee 
114, 119, 145
.
Additionally, many conservatively-treated patients eventually sought surgical treatment to 
manage complications.  In a follow-up study of 40 conservatively-treated patients (average age: 
22 years, range: 15 – 43 years), 30% eventually elected to undergo surgical treatment within 4 
years 
91
.  Similarly, in a study of 18 conservatively-treated pediatric patients, one-third had
elected to undergo surgery within 3 years post-injury 
147
.  Thus, due to the long-term 
consequences and risks associated with ACL deficiency, as well as the higher activity levels of 
younger patients, this treatment is now usually limited to older and less active patients with no 
concomitant knee injuries 
31, 37, 75
.
1.2.2.2 Surgical repair 
Surgical techniques were first developed in the 1960s to repair an injured ACL by 
reapproximating the torn ends using sutures 
163
 
18, 162, 182
.  However, due to the ACL’s poor
healing response, these studies generally achieved limited success.  In 1976, a study by Feagin, 
et al. of West Point cadets who underwent primary repair after ACL injury demonstrated that by 
5 years post-surgery, the majority of patients experienced poor functional outcomes, including 
reinjury, chronic instability, and impairment of daily activities 
61
.  In 1983, a randomized control
trial by Sandberg and colleagues demonstrated no difference between suture repair and 
conservative treatment of the ACL 
182
, while Engebretson and associates showed that replacing
the injured ACL with a soft tissue graft (ACL reconstruction) provided significantly improved 
functional outcomes 
56
.  These findings led to a shift in the late 1970s and 1980s towards ACL
reconstruction, which was successful in immediately restoring stability to the joint. 
7 
1.2.2.3 ACL reconstruction 
ACL reconstruction has become the gold standard of treatment to restore knee stability following 
ACL injury to allow patients to return to sport or work, with the hope of also preventing the early 
development of osteoarthritis.  Today, it is performed on approximately two-thirds of patients 
and is the sixth most common orthopaedic procedure 
84
.
During an arthroscopic ACL reconstruction, the damaged ACL is removed and replaced 
with a soft tissue autograft or allograft, which is fixed into place within tunnels drilled in the 
femur and tibia.  The most popular graft choice is the hamstrings tendon (semitendinosus and 
gracilis) 
47, 143, 238
, although the bone-patellar tendon-bone (BPTB) graft has also been used 
108, 
184, 203, 230, 244
, as well as the quadriceps tendon 
9, 42, 51, 201
.
Although human cadaveric studies 
138, 235, 236
 as well as short-term clinical studies 
238, 239
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have shown that ACL reconstruction could restore stability to the knee immediately after 
surgery, post-operative complications are common and can have a significant effect on a 
patient’s knee-related quality of life.  Graft failure and the need for a subsequent revision surgery 
occur in 10-15% of patients 
79, 172
, and a significant number also experience include graft donor
site morbidity 
117, 197
, extension deficits 
101, 116
, and persistent knee pain or numbness 
48, 178
.
Furthermore, the long-term benefits of ACL reconstruction are unclear, as data on its ability to 
reduce the development of knee osteoarthritis is lacking.  In fact, results from many long-term 
follow-up studies have indicated a high prevalence of osteoarthritis following ACL 
reconstruction that was similar to that following conservative treatment 
7, 50, 72, 105, 107, 119, 207
.  For
example, a recent study found that 10-15 years after ACL reconstruction, 71% of patients 
showed radiographic signs of osteoarthritis, and 24% were classified as moderate to severe 
(Kellgren and Lawrence grade 3 or 4) 
165
.  In another 14-year follow-up study, a three-fold
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increase in the prevalence of osteoarthritis was found in ACL-reconstructed knees compared to 
contralateral uninjured controls 
27
.   
 There are multiple factors that may explain the mechanism behind these long-term 
complications following ACL reconstruction, some of which may actually be attributed to the 
injury rather than the surgery itself.  For instance, degradative biochemical changes may have 
already begun to occur in the knee joint as a result of the ACL injury 
40, 156, 175
.  Futhermore, 
concomitant injuries to other structures in the knee, such as the MCL or medial meniscus 
30, 50, 
139
, may be problematic regardless of treatment of the ACL.   
Other factors may be attributed directly to the ACL reconstruction surgery.  An example 
of this would be iatrogenic problems including damage to the articular cartilage 
246
 or nerves 
89
, 
as well as improper tunnel placement, widening, or over-drilling 
30, 126
.  A lack of proper 
rehabilitation could also impede the recovery process post-surgery.  However, perhaps the most 
significant problem with ACL reconstruction is the inability of the ACL replacement graft to 
replicate the biomechanical function of the native ACL.  Clearly, with its irregular geometry and 
double-bundle structure 
55, 179
, it is not possible to duplicate the complex anatomy and function of 
the native ACL with a soft tissue graft.  Secondly, the preferred autografts for ACL 
reconstruction (hamstrings tendon or BPTB grafts) have been chosen for their strength and do 
not match the stiffness of the ACL 
161, 228
.  Together, these lead to altered knee kinematics and 
over time, they could result in degenerative effects including degradation of the articular 
cartilage.   
1.2.2.4 Rationale for a new treatment option 
With the prevalence of complications following ACL reconstruction, it is logical that either 
improvement in surgical technique would be warranted, or else replacement by a new treatment 
9 
option.  Indeed, a plethora of modifications to ACL reconstruction have been described in 
scientific and medical literature throughout the past 30 years.  A literature search in PubMed on 
“anterior cruciate ligament reconstruction” or “ACL reconstruction” as the search criteria yields 
over 6,000 scientific papers, many of these describing new surgical techniques, graft types, and 
fixation methods.  This abundance of publications on new methods suggests that there is no 
reconstruction method capable of yielding good long-term results, and the quest to improve 
treatment for ACL injury is ongoing.   
Rather than continuing to strive to improve reconstruction, an alternative treatment option 
could be considered to reduce or eliminate the associated complications.  To this end, healing the 
ACL would be an attractive alternative to ACL reconstruction for many reasons.  Similar to 
reconstruction, an effective ACL healing technique could be designed to restore knee stability 
immediately after surgery.  But unlike reconstruction, healing the ACL would preserve its 
complex anatomy, biomechanical properties, and proprioceptive function.  It would also 
eliminate the need for a soft tissue graft or large bone tunnels (up to 9 mm) drilled through the 
femur and tibia.  With a less aggressive surgical procedure, patients would be able to heal faster 
and return to activities of daily living as well as sports-related activities.  Finally, by preserving 
the ACL’s structure and biomechanical function, healing the ACL could succeed where 
reconstruction has not by preventing the early development of osteoarthritis.   
Although the ACL’s low healing capacity is well known, new functional tissue 
engineering approaches have recently been developed that show promise in healing a variety of 
“hard-to-heal” tissues, including the ACL.  These studies give hope to the idea that given the 
appropriate biological and mechanical environment, ACL healing could successfully occur.  
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However, to develop such an approach, understanding and overcoming the complex factors 
limiting its healing intrinsically would be required. 
1.3 LIGAMENT HEALING 
Different ligaments and tendons have been shown to exhibit unique healing responses following 
injury. For example, despite the low healing capability of the ACL and posterior cruciate 
ligament (PCL), the medial collateral ligament (MCL) exhibits a good healing response, even 
without surgical treatment 
71, 100, 227, 229
.  It is likely that the healing response is multi-factorial,
with mechanical forces, vascularity and nutrition, location in the body (intra-articular versus 
extra-articular), and cellularity modulating the healing process.  Due to these differing healing 
capabilities, it is not possible to characterize a “typical” healing process for ligaments and 
tendons.  However, in order to understand how to heal the ACL, it is useful to first understand 
the healing process of ligaments and tendons that exhibit a better natural healing response.  The 
MCL has been extensively studied due to its relatively consistent healing, and is an excellent 
model to provide insight to understand the healing process and to help guide functional tissue 
engineering strategies that could be applied to the healing of other injured ligaments and tendons. 
1.3.1 MCL healing 
Studies of MCL injury have demonstrated spontaneous regeneration of a torn MCL 
71, 215
.  Such
studies have allowed for characterization of 3 distinct, overlapping phases of ligament healing: 
the inflammatory, reparative, and remodeling phases 
71
.  The inflammatory phase begins 
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immediately after injury and consists of formation of a hematoma, proliferation of cells from the 
surrounding tissue, and conversion of the clot into granulation tissue and collagenous tissue 
70
.
After about two weeks, in the subsequent reparative phase, the inflammation diminishes and 
newly formed collagen fibers continue to grow and strengthen.  Finally, two to four weeks later, 
in the remodeling phase, the collagen fibers realign and mature into tissue that is similar to 
normal.  However, unlike the inflammatory and reparative phases, which each last about two 
weeks, the remodeling phase lasts substantially longer, and sometimes months or years are 
required for the healing tissue to reach a pre-injury state 
100, 215
.
In the case of the MCL, it has been found to heal better with non-operative treatment than 
surgical repair 
224
, even in the case of a concomitant ACL injury 
17, 57
.  However, animal studies
have demonstrated that the gross morphology, biochemical composition, and biomechanical 
properties of the healing ligament remained abnormal even after a year 
160, 164, 215
.  With the hope
of improving the quality of the healing MCL as well as other injured ligaments and tendons, new 
augmentation approaches for are being explored, collectively coined as “functional tissue 
engineering.”  
1.3.2 Functional tissue engineering approaches 
With the advent of tissue engineering around the 1980s, biological approaches were developed to 
improve the healing of injured or pathological tissues and organs.  Branching from this, the term 
“functional tissue engineering” was coined in 1998 by the United States National Biomechanics 
Committee (USNBC) to describe the repair or replacement of an injured tissue with cells, 
scaffolds, growth factors, or proteins, with the goal of restoring its biomechanical function 
38
.
Among the factors of importance for the creation of such an approach are the understanding of 
12 
the native in vivo environment and tissue, including the time-varying stress and strain, fluid 
pressure and flow, and biomechanical properties.  Clearly, with their important biomechanical 
functions, preserving or restoring these would be key for successful healing of injured ligaments 
and tendons.  Thus, many researchers have applied principles of functional tissue engineering to 
improve the healing of these tissues, using a variety of methodologies. 
1.3.2.1 Growth factors 
Many growth factors have been identified that play important roles in the process of ligament 
and tendon healing, including fibroblast growth factor (FGF), transforming growth factor beta 
(TGF-β), vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) 
148, 183
. As such, researchers have applied individual growth factors as therapeutic agents for 
functional tissue engineering, with promising results.  For example, after surgical transection of 
the rabbit MCL, the administration of TGF-β2 led to improvement in the structural properties of 
the healing femur-MCL-tibia complex (FMTC) 
195
.  However, reported results have been mixed,
particularly when a combination of growth factors has been employed.  PDGF or a combination 
of PDGF and FGF also led to improvements in the structural properties of a healing bone-
ligament-bone complex, although a combination of PDGF and insulin-like growth factor Type 1 
did not 
128
.  Similarly, the application of PDGF-BB led to improvements in the structural
properties of the FMTC, while the addition of TGFβ-1 did not result in additional improvements 
92
 and TGFβ-1 alone did not improve healing. 
More recently, as an autologous source of multiple growth factors including PDGF-2 and 
VEGF, many have investigated the use of platelet-rich plasma (PRP) for soft tissue healing 
58
.
PRP has also been applied clinically in a variety of musculoskeletal procedures, including 
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treatment of patellar 
124
 and Achilles tendinopathy 
77
, rotator cuff repair 
176
, treatment of cartilage
lesions 
166
, and ACL reconstruction 
166
.  However, despite the clinical interest and widespread
media coverage, the efficacy of PRP for treatment of musculoskeletal injuries remains unknown, 
as there have not been randomized controlled clinical studies demonstrating the efficacy of PRP 
treatment for ligament and tendon healing 
168, 185, 200
.
1.3.2.2 Stem cells 
In addition to the application of growth factors, stem cells have also been used for the healing of 
ligaments and tendons 
44, 88, 127
.  In a rabbit study, autologous, marrow-derived mesenchymal
stem cells (MSCs) suspended in a collagen gel were found to improve the structural properties, 
cross-sectional area, and collagen fiber alignment following an Achilles tendon gap injury 
241
.
Similarly, MSCs were also found to improve the incorporation of a hamstrings tendon autograft 
following ACL reconstruction in a rabbit model, with a near-normal insertion site and increased 
stiffness and ultimate load compared to control groups 
134
.  However, as a therapeutic agent, the
delivery mechanism and biological and mechanical environments would be important to ensure 
appropriate differentiation for the intended healing application 
43, 249
.
1.3.2.3 Extracellular matrix scaffolds 
Extracellular matrix (ECM) bioscaffolds are composed of naturally-occurring ECM derived from 
animal or human tissue that has been decellularized and lyophilized 
22
.  Common sources include
the porcine small intestine submucosa (SIS) 
20, 24, 122, 174
 and urinary bladder matrix (UBM) 
21, 23
.
These scaffolds have been used since the 1990s for the healing of various injured tissues and 
organs, and can be prepared as single or multi-laminate sheets 
73
 as well as powders 
81, 205, 231
.
By retaining the natural composition of the tissue (collagen, elastin, glycosaminoglycans, 
14 
glycoproteins, and growth factors) 
22, 93, 209
, as well as retaining their natural architecture, the
scaffolds and their degradation products could assist in biological and mechanical augmentation 
of an injured tissue to promote site-specific, constructive remodeling 
53
.  With an additional
pepsin digest, an ECM hydrogel can also be prepared to be used for injectable applications 
74, 221, 
222
.  Many ECM-derived products have been approved by the Food and Drug Administration and 
used clinically for therapeutic applications 
21
, including those in orthopaedic applications 
53, 206
.
In the past 15 years, millions of allogeneic and xenogeneic ECM scaffolds have been implanted 
in patients worldwide 
118
.
The host response to ECM bioscaffolds involves the source tissue, processing methods, 
and other device-specific factors 
118
.  Ultimately, the goal of ECM scaffolds is to manipulate the
healing response away from scar tissue deposition and towards the site-specific regeneration of 
functional tissue.  The mechanism behind which these scaffolds promote constructive 
remodeling is not yet completely understood, but is heavily influenced by the recruitment of 
stem and progenitor cells to the injury site 
5
, as well as modulation of the immune response 
67
.  In
particular, a relationship between T helper (Th) cell response and constructive remodeling has 
been found, whereby ECM scaffolds promoted the Th2 phenotype (wound-healing, anti-
inflammatory 
146
)  as opposed to the Th1 phenotype (pro-inflammatory, implant rejection) 
21
.
Similarly, macrophage polarization has been found to be a strong indicator of the healing 
response, and ECM bioscaffolds have been found to promote the M2 phenotype (anti-
inflammatory, constructive remodeling 
16
) in favor of the M1 phenotype (pro-inflammatory,
pathogen killing) 
26, 188
.
ECM bioscaffolds have yielded promising results when used for the healing of ligaments 
and tendons 
25, 80, 152
.  For example, when used for repair of a 1.5 cm Achilles tendon defect in
15 
dogs, a multi-laminate scaffold derived from the porcine SIS had fully degraded by 60 days after 
surgery, and by 90 days had been replaced with organized, aligned collagen tissue that was 
histologically similar to that of the native tendon 
80
.  In addition, when a 10-ply multi-laminate
SIS sheet was applied to repair a completely resected infraspinatus tendon in dogs, the defect 
was completely filled in by 3 months of healing 
52
. The gross and histologic appearance of the
healing tendon was similar to the native tendon, with a well-organized, aligned collagen matrix.  
With these promising results using ECM scaffolds for tissue regeneration, our research 
center has studied the application of these scaffolds for the healing of an MCL gap injury 
133, 152, 
225
 as well as a patellar tendon defect 
115
.  When an SIS sheet was applied to a 6 mm gap injury
of the rabbit MCL, the SIS-treated MCL had improved collagen fibril alignment with larger 
collagen fibril diameters compared to a control group with a non-treated defect, as well as a 
collagen V/I ratio that was closer to that of the native MCL 
225
.  Results of uniaxial tensile testing
also showed that the SIS-treated FMTC had a tangent modulus that was 88% higher than that of 
the control group.  When this study was extended to 26 weeks of healing, the mechanical 
properties of the healing MCL were again improved significantly over the control group, with a 
33% increase in Young’s modulus and a 50% increase in tensile strength 133.
In addition to the MCL, our research center also explored the application of SIS for the 
healing of a patellar tendon defect, applying SIS strips to the anterior and posterior sides of a 
central-third defect in rabbits 
115
.  By 12 weeks of healing, the defect had been filled in
completely with healing tissue, whereas the neo-patellar tendon in a non-treated control group 
could not fill the space.  The SIS-treated patellar tendons were also composed of collagen fibers 
with better organization and alignment than those of the control, with more spindle-shaped cells.  
Biomechanically, the stiffness of the SIS-treated bone-patellar-tendon-bone complex was 98% 
16 
higher than that of the non-treated group, and the ultimate load was 113% higher.  Thus, the 
results of these studies demonstrated the potential of ECM bioscaffolds to successfully heal 
ligaments and tendons. 
1.3.3 Challenges for ACL healing 
With the advances in functional tissue engineering and promising results demonstrating the 
healing of other tissues, healing the ACL has become an encouraging possibility in spite of its 
low intrinsic healing capability.  However, the limitations to ACL healing are complex and 
multi-factorial, and pose a unique challenge for functional tissue engineering.  In humans as well 
as in animal models, it has been observed that the ACL rapidly degenerates after injury in as 
little as 6 weeks 
14, 213
.  Although the mechanism behind this rapid degeneration is only partially
understood, it is clear that biological and mechanical factors both play a significant role.  
Biologically, differences observed between the MCL and ACL in vitro and in vivo have 
shed light on the mechanisms behind the ACL’s poor healing response.  In a side-by-side 
comparison of primary cell lines derived from the ACL and MCL, ACL fibroblasts were found 
to exhibit significantly reduced proliferation and migration 
15, 153
, as well as a differential
expression of matrix metalloproteases (MMPs) and tissue inhibitors of metalloproteases (TIMPs) 
248
.  This suggests that even at the cellular level, the ACL is at a disadvantage for healing.  The 
ACL has also been found to have reduced cellularity and vascular supply compared to the MCL, 
which could also limit its healing response 
34, 55
.  In a rabbit study of partial transection of the
ACL or MCL, the MCL was found to have increased blood flow and an angiogenic response, 
while the ACL had a minimal vascular response and showed signs of atrophy 
33, 35
.  Finally, the
17 
loss of the synovium is likely one of the ACL’s most significant biologic barriers to healing, as 
this outer sheath protects it from the harsh synovial environment of the knee joint.  Indeed, it was 
found that removal of the synovial layer led to an increase in collagenase production and 
degradation of the ACL remnants 
13
.  The exposure of the injured ACL to synovial fluid
following the loss of the synovium could in turn prevent the formation of a hematoma, which 
would be a crucial step in the healing process as a bridging scaffold between the two torn ends. 
In addition to these biological factors, mechanical factors also limit the ACL’s ability to 
heal.  Due to its primary role in knee stability, a gap would form between the two torn ends 
following injury, with its width changing based on the loading of the knee.  Thus, even if a 
bridging scaffold were able to form, the slowly-forming neo-tissue would likely be pulled apart 
before it could fully regenerate.   
With these multi-factorial barriers to healing, a functional tissue engineering strategy to 
successfully heal the ACL would face particular obstacles to overcome them.  
1.3.4 Current and new approaches to ACL healing 
Much as the barriers to ACL healing can be divided into biological and mechanical factors, the 
strategies employed to engineer the healing of the ACL can be divided similarly.  Since the 
1990s, the majority of work on ACL healing has focused on biological augmentation of the 
injured ACL to help to stimulate and accelerate tissue growth and remodeling.  However, within 
the past 10 years, mechanical augmentation methodologies have also been explored, and most 
recently, these techniques have been combined for a combined approach for ACL healing. 
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1.3.4.1 Biological augmentation 
Early work on biological augmentation of an injured ACL included the application of hyaluronic 
acid 
216
, individual growth factors 
120
, and mesenchymal stem cells 
6, 113
.  These studies reported 
increased neo-tissue formation and organization of the healing ACL compared to an untreated 
control group, but the morphological appearance and biomechanical function of the healing ACL 
were abnormal and inferior to that of the native ACL.   
 For the past 10 years, Murray and associates have studied ACL healing using a collagen-
PRP hydrogel, which was injected into the defect of a transected ACL to act as a bridging 
scaffold between its two torn ends 
151
.  By 15 weeks of healing in a porcine model, the addition 
of PRP led to significant improvements in neo-tissue formation and remodeling, structural 
properties of the FATC, and cellularity compared to a second group treated with a collagen 
hydrogel alone.  However, significant hypertrophy of the PRP-treated ACL was observed, with 
the average cross-sectional area more than twice that of the normal ACL.  The structural 
properties of the healing FATC were also found to be significantly lower than those of the 
normal FATC, reaching only 26% and 18% of its stiffness and ultimate load, respectively.  Thus, 
treatment of the ACL with the collagen-PRP hydrogel led to abundant scar tissue formation that 
did not restore its biomechanical function.  The authors speculated that this may be due to the 
inability of the suture repair technique to restore stability to the joint immediately after surgery, 
which could affect the loading and remodeling of the healing ACL 
150
. 
Given the encouraging results in our research center using scaffolds derived from the 
porcine ECM for the healing of a patellar tendon defect 
115
 and a 6 mm wide MCL gap injury 
133, 
152
, these scaffolds were next applied in sheet and hydrogel form to successfully heal a fully 
transected ACL in a goat model 
66
.  At 12 weeks post-surgery, the healing ACL had an organized 
19 
collagen matrix with spindle-shaped cells, but without hypertrophy.  Biomechanical testing 
revealed that the stiffness of the healing femur-ACL-tibia complex (FATC) was 2.5 times greater 
than suture repair alone, and the ultimate load was 90% higher.  These results on the gross 
morphology and tensile properties were close to those obtained in another study that utilized 
ECM bioscaffolds with a locking suture repair technique for healing of a transected ACL in 
goats 
158
.
However, when our laboratory performed a second study at a subsequent longer time 
point; i.e., 26 weeks, the mode of failure was found to have moved from the midsubstance (at 12 
weeks) to its femoral insertion.  This was a result of continuing improvement of the healing ACL 
while its insertion sites became weakened due to the lack of adequate stress in the FATC 
227
.
These results also suggested that biological augmentation alone was not able to adequately load 
the ACL, and mechanical augmentation would be needed to limit the disuse atrophy of its 
insertion sites.  
1.3.4.2 Mechanical augmentation 
Published in vitro 
65, 68
 and in vivo 
150
 studies have shown that mechanical augmentation of an
injured ACL could help to stabilize the knee, leading to improvement in its healing.  For 
example, when sutures were applied to provide bone-to-bone fixation between the femur and 
tibia, joint stability could be restored, as well as the functions of the ACL and medial meniscus 
when the knee was subjected to externally applied loads 
65
.  The same technique used in an in
vivo study also led to an improved healing response of a transected ACL when compared with a 
suture repair technique alone 
150
.  However, due to the slow process of ACL healing and
aforementioned limiting factors, mechanical augmentation alone would also not be able to 
successfully regenerate an injured ACL. 
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1.3.4.3 Combined biological and mechanical augmentation 
While biological and mechanical augmentation have separately shown promise in healing a 
transected ACL, it is likely that a combined form of biological and mechanical augmentation 
would be required for its full regeneration.  While mechanical augmentation would restore 
stability to the knee immediately after surgery and help to load the healing ACL to prevent 
disuse atrophy of its insertion sites, biological augmentation would stimulate and accelerate the 
healing response.  Combined, these approaches would work together to restore both the form and 
biomechanical function of the native ACL. 
Murray and colleagues studied ACL healing using combined biological and mechanical 
augmentation in a porcine model 
150
.  Using bone-to-bone fixation between the femur and tibia to
complement their collagen-PRP hydrogel, they found improvements in the structural properties 
of the FATC compared to a second group with collagen-PRP hydrogel alone.  However, no 
differences could be observed in the anterior-posterior joint laxity, which was significantly 
higher than that in the normal joint.  Furthermore, the structural properties of the healing FATC 
in both treatment groups remained well below those of the normal FATC.  Thus, further work on 
ACL healing using combined biological and mechanical augmentation is warranted. 
1.4 MAGNESIUM AS A BIOMATERIAL FOR ORTHOPAEDIC APPLICATIONS 
1.4.1 Background on orthopaedic biomaterials 
Biomaterials are often used in orthopaedic surgery for bone substitutes, fixation, and stabilization 
of fractured bones, ligament and tendon reconstruction procedures, total joint arthroplasties, and 
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so on.  Historically, non-degradable metals, namely stainless steel, cobalt-chromium, and 
titanium alloys, have been commonly used because they possess good mechanical strength, 
biocompatibility, and corrosion resistance.  However, because they do not degrade and remain 
present in the body indefinitely, their removal requires secondary surgeries.  In addition, due to 
wear processes, they sometimes release toxic metallic particles into the body that could lead to a 
cytotoxic response 
103, 104, 194, 212
.   
However, with the advent of functional tissue engineering, the potential for regenerating 
tissues as well as their biomechanical function has been realized.  Thus, bioresorbable materials 
have gained much attention and their usage has increased, as they could be replaced by the 
patient’s own tissue over time, as well as be used for delivery of bioactive molecules to improve 
healing of various hard and soft tissues 
155
.  These biomaterials are chosen based on the needed 
properties for the desired application, including specific mechanical properties, porosity, 
degradation profiles, biocompatibility, and adherence and incorporation into adjacent tissue. 
Depending on the specific structure, properties, and function of the tissue to regenerate, 
there are now many options for biomaterials in orthopaedic surgery 
155
.  For the repair or 
replacement of ligaments and tendons, fibrous collagen, extracellular matrix, silk, and synthetic 
polymer scaffolds have been explored 
78, 206, 245
.  In addition, hydrogels have become an 
attractive option to fill irregularly-shape voids and aid in the delivery of cells, growth factors, 
and other bioactive molecules 
54
.  For regeneration of the soft tissue-to-bone interface (e.g. ACL 
insertion to the femur), polymers have become a popular choice as they can be engineered to 
possess multi-phasic properties 
140
. 
However, polymeric materials may not be an ideal choice for some orthopaedic 
applications. With poly-L-lactic acid (PLLA) interference screws were used for graft fixation 
22 
during ACL reconstruction, the devices often fractured during implantation due to their 
brittleness 
190
.  Further, their rate of degradation varied greatly between patients and in most
cases was very slow, with the screw remaining intact even after 2 years 
106
.  Also, after
degradation, the void left was not filled with regenerating bone.  A 10-year follow-up study 
showed that an osseous cyst had formed after complete degradation of an interference screw 
210
.
Thus, an alternative resorbable biomaterial that eliminates these complications would be 
advantageous.  
To this end, one of the most promising classes of orthopaedic bioresorbable materials is 
magnesium (Mg) and its alloys.  Due to the advantageous and desirable properties of these 
materials, there has recently been increased interest in these materials for biomedical 
applications.  In fact, a search of Web of Science using “magnesium” and “stainless steel” as 
search queries under the category “biomaterials” revealed that the number of publications on Mg 
has exponentially increased in the past ten years, compared to those on stainless steel, which 
only saw a modest increase (Figure 3). 
Figure 3: Histogram showing the number of publications each year on research of Mg and its alloys and 
stainless steel as biomaterials 
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Mg-based materials have significantly lower moduli than titanium-based materials (41-45 
GPa vs. 110-117 GPa) 
97
.  As a result, their mechanical properties are closer to those of cortical
bone and could reduce the level of stress-shielding when used as bony implants.  In terms of 
tensile strength, Mg-based materials are 3-16 times stronger than polymers (160-250 MPa vs. 16-
69 MPa).  They are also more ductile and have a higher ultimate strain that reaches up to 16%, 
which could reduce the risk of device fracture during implantation.  These alloys have the 
mechanical properties required to meet loading requirements during and after implantation, but 
would not interfere with common imaging modalities for post-operative care, such as MRI and 
CT. 
1.4.2 Biocompatibility 
The biocompatibility of Mg in humans has been well established, as it is naturally present in the 
human body and is responsible for numerous physiological processes, including protein 
synthesis, control of blood glucose, nerve and muscle function, development of bone, 
maintenance of normal heart rhythm, and regulation of blood pressure 
198, 208
.  The adult human
body contains about 1 mol (24 g) of Mg, which is found primarily in the bone (60-65%) and 
muscles (27%).  Mg in the body can be acquired through diet, medication, or commercially-
available oral supplements, with a recommended maximum intake of 250-350 mg per day.  
Uptake of Mg in the human body is mostly through the ilium and jejunum, with excess excreted 
through the kidneys.  Due to the body’s ability to eliminate excess Mg, high doses in a healthy 
individual are generally not problematic; however, Mg toxicity has been noted with extreme 
intakes (> 5,000 mg/day).  
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1.4.3 Historical use of Mg for orthopaedic implants 
The initial use of bioresorbable Mg implants in orthopaedic surgery was during the early 
twentieth century, with Mg implants used for regaining or preservation of joint motion, fracture 
fixation, and bony separation 
217
.  In both human and animal studies, a number of investigators
reported that Mg implants stimulated soft tissue production and promoted new bone growth, 
while being completely resorbed over time 
144, 252
.
However, the most common complication was rapid degradation, coupled with pockets of 
hydrogen gas formation around the Mg implants 
217
.  Although the gas evolution was reported as
not harmful to the surrounding tissue and did not cause any adverse clinical effect such as 
infection, the inability to control the rate of degradation in vivo led to the abandonment of the use 
of Mg.  Surgeons had then gone on to use more corrosion-resistant metals, such as stainless and 
titanium. 
1.4.4 Recent advances in Mg materials 
To combat the aforementioned challenges involving the use of Mg in orthopaedics, new methods 
for alloying, coating, surface treatment, and processing have been developed to control 
mechanical properties, corrosion rate, and biocompatibility.  These have resulted in the 
development of materials with improved properties that have renewed the possibility that Mg 
could be promising for orthopaedic applications.   
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1.4.4.1 Alloying and mechanical properties 
With a yield strength of 21 MPa as-cast and 115-140 MPa as-rolled, pure Mg possesses 
mechanical properties that may be not be strong enough for loading-bearing biomedical 
applications 
251
.  However, the alloying of Mg with various elements has led to the development
of many materials with greatly enhanced mechanical properties.  With these improvements, Mg 
materials are better-suited for use as biomaterials for orthopaedic applications, where the ability 
to withstand loading without failure is of key importance.  Among the most common Mg alloys 
are those including aluminum (Al), which increases the corrosion resistance by forming an 
insoluble layer of Al2O3 on its surface when exposed to simulated body fluid (SBF) 
219
.  Al has
commonly been alloyed with zinc (Zn) to produce popular alloys AZ31 (3% Al, 1% Zn), AZ61 
(6% Al, 1% Zn), and AZ91 (9% Al, 1% Zn) 
121
, as Zn increases material strength and is accepted
to be biocompatible 
41, 219
.  With its similar advantageous properties, calcium (Ca) has also
commonly been used as an alloying element in Mg alloys, and is particularly attractive for bone 
healing applications 
130, 131
.  Recently, rare earth metals, including yttrium (Y), zirconium (Zr),
and neodymium (Nd) have also been used in Mg alloys due to their improvements on the 
mechanical properties, creep resistance, and corrosion rate of Mg 
45, 96, 97, 220
.
In addition to altering its composition by alloying, others have used different strategies to 
modify the microstructure of the Mg material to change its properties.  For example, a Mg 
calcium phosphate scaffold was designed to be porous in order to have its mechanical properties 
similar to those of cancellous bone, thus making it ideal to be used as a bone substitute 
214
.
Others have investigated the growth of monocrystalline forms of Mg (single crystal Mg), which 
eliminates grain boundaries and has improved ductility, exhibiting superplastic behavior 
109, 135, 
186, 187, 193
. 
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1.4.4.2 Corrosion behavior 
Pure Mg degrades in an aqueous environment via an electrochemical reaction to produce 
magnesium hydroxide and hydrogen gas (Equation 1).  
𝑴𝒈
(𝒔)
+ 𝟐𝑯𝟐𝑶(𝒂𝒒) →  𝑴𝒈(𝑶𝑯)𝟐 (𝒔) + 𝑯𝟐 (𝒈) (1) 
Although these corrosion products are not cytotoxic, the rapid degradation of pure Mg is 
of concern for medical applications, particularly when corrosion-enhancing impurities are 
present, such as iron, copper, or nickel 
251
.  The accompanying generation of excess amounts of
hydrogen gas would be undesirable for clinical applications, as it could impede healing and lead 
to complications.  As noted in Section 1.4.3, this has historically been the most significant 
limiting factor in the use of Mg in orthopaedic applications 
217
.
Fortunately, with advances in alloying and processing capabilities, the corrosion rate of 
Mg materials has been greatly improved.  Elements that have been shown to improve the 
corrosion resistance of Mg include Al 
192
, Y 
219
, Ca 
232
, Mn 
234
, Zn 
191
, and Zr 
191
.  Modifications
of the material surface using treatments and coatings have also been developed to slow the 
corrosion of Mg 
102, 251
.  One of the most well-established surface coating to reduce the corrosion
rate of Mg alloys is the generation of a surface oxide layer using anodization.  Techniques 
including anodic oxidation and micro-arc oxidation (also called plasma electrolytic oxidation, or 
PEO) have been commonly used for their corrosion-resistant properties 
32, 85, 243
.  A calcium-
phosphate (Ca-P) coating can also be achieved through relatively simple chemical treatment and 
has been shown to slow down degradation of AZ31 by 2 orders of magnitude 
102
.  Further,
polymers such as PLGA have been used to control degradation of Mg-based alloys 
167
, although
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challenges of durability still remain.  Other coating methods that have been shown to be effective 
are physical vapor deposition of high-purity Mg 
181
, fluoride treatment 
218, 237
, and alkaline-heat
treatment 
86
.
1.4.4.3 In vitro and in vivo cytocompatibility and healing potential 
However, despite the promise of new Mg materials with enhanced mechanical and corrosion 
properties, their cytocompatibility must be demonstrated to determine their potential to be used 
in biomedical applications.  To this end, a number of experiments have been performed to screen 
for cytocompatibility of these materials using in vitro and in vivo experiments.   
By culturing U2OS (osteoblast) cells with or without a Mg  (99.95% purity) sample, it 
was found that there were no differences in cell viability or proliferation, not mineralization 
242
.
Similarly, when fibroblasts, osteoblasts, or blood vessel-related cells were cultured on 9 different 
Mg alloys, no significant reduction in cell viability was observed 
87
.  But in addition to being
cytocompatible, many studies have indicated that Mg may elicit a therapeutic effect on cellular 
activity.  When mouse fibrosarcoma cells (L-929) cells were cultured with extracts prepared 
from Mg alloys, increased viability was found compared to control groups 
131
.  Further, a Mg-
based alloy (AZ21; Al 2% wt and Zn 1% weight) could support stromal cells and promote their 
differentiation toward osteoblast-like phenotypes in vitro 
171
.  Using a scaffold with a 
biomimetic, porous microstructure also proved to be positive for cellular activity, as MG63 cells 
seeded on a microporous/macroporous Mg-Ca-P scaffold showed significantly better cell 
proliferation and attachment as well as osteoblast differentiation than those seeded on a Ca-P 
cement scaffold 
214
.  Incorporating coatings to these alloys has also been shown to elicit a
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beneficial effect on cells.  For example, when L-929 cells were cultured on a Ca-P-coated Mg-
Mn-Zn alloy, significant improvements in cell proliferation were found 
233
.  Thus, these in vitro
experiments demonstrated that Mg and its alloys are cytocompatible. 
In contrast to these positive results, it should be noted that some in vitro studies using 
static cell culture have reported significant reduction in cell viability when cultured with high 
concentrations of extracts prepared from Mg materials 
45, 96
.  This is believed to be due to
osmotic shock caused by the increased osmolality of the extract solution, as well as the increased 
pH of the extract solution as the Mg alloy degrades.  However, these high concentrations are 
believed to be outside of the physiological range expected in vivo, and ten-fold extract dilutions 
have thus been recommended to study the cytotoxicity of Mg materials 
62, 211
.
Following in vitro experiments, live animal studies have also been conducted to evaluate 
the in vivo biocompatibility and degradation of Mg and its alloys for orthopaedic applications.  
To date, a majority of these experiments have focused on the use of Mg for bone healing 
applications.  These studies have demonstrated that Mg-based materials are biocompatible with 
potential osteoinductive effects as well. 
In a comparative study, 4 alloys, including AZ31 (Al 3% wt, Zn 1% wt), AZ91 (Al 9% 
wt, Zn 1% wt), WE43 (Y 4% wt, other rare earth metals 3% wt, and Zr 0.4% wt), and LAE442 
(Li 4% wt, Al 4% wt, and rare earth metals 2% wt) were implanted in the femora of guinea pigs 
for 6 and 18 weeks 
220
.  The degradable polymer, poly-96L/4D-lactide was used as a control.  In
the Mg alloy groups, there were statistically significant increases in bone mass and mineral 
apposition rate at both 6 and 18 weeks, as well as more trabecular-like structures compared to the 
control.  Furthermore, when Mg-Ca rods were implanted in the femora of rabbits, the implants 
were found to have degraded within 3 months, with new bone formation and high activity of 
29 
osteoblasts and osteocytes at the implant site 
131
.  Thus, the osteoinductive capacity of Mg-based
materials could be demonstrated.   
Investigators have also alloyed or coated Mg with elements naturally found in the human 
body, e.g. Ca, Zn, Mn, F, etc. to test their in vivo biocompatibility and osteoinductivity.  Zhang, 
et al. tested a Mg-Zn-Mn alloy in the femora of Sprague-Dawley rats and observed significant 
degradation (~50%) at 26 weeks together with newly formed bone on the degrading surface 
without fibrous tissues 
247
.  In another study, a Mg-Za alloy was coated with magnesium fluoride
(MgF2) and implanted in the femora of New Zealand white rabbits 
202
.  Although the presence of
the coating was not found to significantly affect the corrosion resistance of the implants, by 3 
and 6 months, there was significant endosteal and periosteal growth on both coated and uncoated 
implants, with bone trabeculae tightly adhered to the implant surfaces.   
Modifying the porosity of the Mg scaffold was also explored in vivo.  When a 
microporous/macroporous Ma-Ca-P scaffold was implanted into femoral bone defects in rabbits, 
new bone tissue had formed into the pores of the scaffold by 2 months of healing, and after 6 
months, the majority of the scaffold had degraded.  In fact, 81% of the bone defect had been 
replaced by new bone tissue by 6 months, compared with just 47% in a 
microporous/macroporous calcium phosphate control.   Additionally, numerous osteoblasts were 
visible in a newly-formed osteoid matrix, and the interface between the scaffold and bone was no 
longer visible 
214
.  Thus, the combination of a Mg alloy with a porous structure may be
advantageous as a biomimetic approach to functional tissue engineering of bone. 
These in vivo studies demonstrated that Mg materials could promote bone formation and 
appropriate degradation rates for replacement by new bone tissue, without cytotoxic effects.  
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These positive results encourage the further study and development of Mg devices for 
orthopaedic applications. 
1.4.5 Rationale for use of Mg for ACL healing 
With the aforementioned advantages for Mg and its alloys, these biomaterials are promising for 
mechanical augmentation of an injured ACL. They are lightweight and possess suitable 
mechanical properties such that they could withstand loading in vivo without fracture or loss of 
form; however, due to their ductility, they could undergo deformation to conform to the 
geometry of the knee to potentially prevent damage to the cartilage, menisci, and other knee 
structures.  In addition, the known biocompatibility of Mg would be attractive for the clinical 
translation of an ACL healing device.  But most importantly, because Mg alloys possess 
controllable degradation, with measured mass loss rates for different Mg alloys determined to be 
from < 0.1 – 100 mg cm-1 day-1 121, an alloy and corrosion-resistant surface coating could
strategically be selected to allow for the gradual transfer of loading from the mechanical 
augmentation device to the healing ACL throughout the healing process (3 – 6 months).  As 
illustrated in Figure 4, the Mg device would protect the injured ACL immediately after surgery 
by assuming the normal function of the ACL, allowing neo-tissue to form between its two torn 
ends.  Then, as the ACL healed and the device degraded, the contribution to ACL function would 
shift to the healing ligament.  Eventually, the device would disappear, leaving only a healed, 
functional ACL.   
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Figure 4: Gradual shift in the contribution to ACL function over time of a Mg device versus the healing tissue 
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2.0 OBJECTIVES 
2.1 OVERALL GOALS 
The overall goal of our research center was to develop a novel approach to heal and regenerate a 
torn ACL by means of combined biological and mechanical augmentation.  The specific 
objectives of this dissertation were to develop a “ring” device made of bioresorbable Mg to 
reconnect the two ends of a transected ACL, and to quantitatively evaluate its potential for ACL 
healing in vivo when used alongside extracellular matrix bioscaffolds.  To accomplish these 
objectives, the following three Specific Aims were proposed. 
2.2 SPECIFIC AIMS 
Specific Aim 1: To design a Mg ring device for mechanical augmentation of a surgically 
transected ACL in a cadaveric goat model.  Although biological augmentation has shown 
promise in healing a transected ACL, mechanical augmentation is also needed due to its slow 
healing process to restore joint stability and load the ACL so that deterioration of its insertion 
sites due to disuse atrophy in the early stages of healing could be prevented.  As a result, a 
bioresorbable, ring-shaped device made of magnesium (Mg) was designed to reconnect the two 
ends of a transected ACL.  Mg and its alloys were selected as a material for this device because 
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they possess controllable degradation and suitable mechanical properties, as well as known 
biocompatibility.  For this Aim, we wished to address the following research questions:  
1) Could a Mg ring device be designed and manufactured to connect the two ends of a surgically
transected goat ACL?  
2) What would be the preferred geometry and Mg material such that the device would be suitable
to withstand loading in vivo? 
Specific Aim 1.1: To design and fabricate a Mg ring device and develop a corresponding 
suture technique for repair of a surgically transected ACL in a cadaveric goat stifle joint. 
Success Criteria: The Mg ring design must be successfully manufactured from Mg stock 
materials, suitable for implantation to repair a surgically transected goat ACL, and able to 
load the ACL upon implantation by bringing together the transected ends. 
Specific Aim 1.2: To evaluate the Mg ring device design using a parametric finite element 
analysis to select a suitable design for further in vitro and in vivo testing.  Testing of 
preliminary prototypes indicated that applying anterior tibial loads to a cadaveric goat stifle 
joint after implantation of the Mg ring (Mg ring repair) could lead to deformation or fracture 
of the device.  In vivo, premature failure of the device may be problematic as it could 
compromise device function as well as release Mg fragments into the joint space.  We thus 
sought to address the research question of whether modifying the device design or Mg 
material could reduce the potential for device fracture.  The selection of a suitable Mg ring 
design was made based on results of a finite element analysis after applying loads simulating 
in-situ forces on the device after Mg ring repair.  Parameters of interest were suture hole 
diameter, notch depth, and Mg alloy, and model outputs were the maximum Von Mises stress 
and stress distribution. 
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Success Criteria:  The maximum Von Mises stress in the Mg ring device as determined 
by the finite element analysis must not exceed the failure strength of the selected Mg 
material.  A suitable design will also be selected based on its ability to reduce the 
maximum stress and stress concentrations on the device.   
Specific Aim 2: To quantitatively evaluate the ability of the Mg ring repaired ACL to restore 
stifle joint kinematics and in-situ forces in the repaired ACL.  For successful mechanical 
augmentation of an injured ACL, it would be necessary to restore joint stability and in-situ forces 
in the ACL to near normal levels such that it would be adequately loaded throughout the healing 
process.  In vitro testing using cadaveric goat stifle joints was performed to evaluate the stifle 
joint kinematics and in-situ forces in the Mg ring-repaired ACL at three preselected angles of 
joint flexion under externally-applied loads simulating those used in clinical examinations. 
Hypothesis: Previous work in our research center on repair of a transected ACL has shown 
that suture repair could restore anterior tibial translation to within 9 mm of the joint with the 
intact ACL, and in-situ forces in the ACL to within 12 N of normal 
64, 65
.  Due to the
additional mechanical augmentation provided by Mg ring repair, we hypothesized that the 
Mg ring-repaired ACL would be able to restore anterior tibial translation of the Mg ring-
repaired ACL to within 6 mm of that of the intact joint, and in-situ force in the repaired ACL 
to within 10 N of those in the intact ACL. 
Specific Aim 3: To evaluate the biocompatibility and efficacy of the Mg ring for ACL healing.  
While Mg and its alloys are generally considered to exhibit suitable biocompatibility, some 
studies have also reported potential enhancement of the healing response when used in 
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applications such as bone and blood vessel regeneration.  However, the use of Mg for healing of 
ligaments and tendons has not yet been studied.  As the Mg ring was intended to be combined 
with ECM bioscaffolds, knowledge of therapeutic effects of Mg would be important in vivo to 
help to understand whether ECM alone is modulating the healing response, or if Mg could also 
enhance healing.  Thus, we first wished to assess address the research question: What are the 
effects of Mg materials on the growth and function of goat ACL fibroblasts?  With these results, 
we proceeded to a live animal model to address the question: Could mechanical augmentation 
using the Mg ring combined with biological augmentation using an ECM bioscaffold lead to 
successful healing of a surgically transected goat ACL? 
Specific Aim 3.1: To determine the effects of single crystal Mg and 4 Mg alloys on goat ACL 
fibroblasts in terms of cell growth and function.  Extracts of single crystal Mg and 4 Mg 
alloys (Mg-Zn-Sr-Zr alloys ZJ40 and ZJ41, Mg-Ca-Zr, and AZ31) were prepared by 
incubating Mg stock materials in cell culture media.  These extracts were diluted serially and 
used to culture goat ACL fibroblasts.  At 3 days of culture, the resulting cell proliferation and 
total soluble collagen produced were measured. 
Hypothesis:  Recent literature from in vitro and in vivo studies has suggested that Mg 
may enhance cellular function and tissue healing in orthopaedic applications 
131, 171, 214, 220, 
233
. Thus, we hypothesized that lower extract concentrations considered to be 
physiologically relevant 
62, 211
 (< 25% extract) would lead to significantly higher levels of
cell proliferation and collagen production compared to non-supplemented cell culture 
media.  However, at higher extract concentrations (≥ 25% extract), the proliferation and 
collagen production would both decrease due to osmotic shock caused by the increased 
osmolality of the extract solution.   
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Specific Aim 3.2: To assess the positive effects of the Mg ring in combination with an 
extracellular matrix bioscaffold on healing of a surgically transected goat ACL at 6 and 12 
weeks.  For a 6-week pilot study, the gross morphology, histological appearance, and 
degradation of the Mg ring were assessed.  For the 12-week study, the cytology and total 
protein content of the joint synovial fluid, joint stability, in-situ forces in the ACL, and 
structural properties of the femur-ACL-tibia complex of treated joints and their respective 
contralateral sham-operated controls were measured.   
Hypothesis:  We hypothesized that combining the Mg ring (mechanical augmentation) 
with the ECM bioscaffold (biological augmentation) would lead to improved ACL 
healing, as the Mg ring stabilized the stifle joint and loaded the healing ACL, while the 
ECM bioscaffold stimulated and accelerated the healing response.  As a result, the joint 
stability, biomechanical properties of the femur-ACL-tibia complex, and 
histomorphology of the healing ACL would be enhanced. 
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3.0 DESIGN AND FINITE ELEMENT ANALYSIS 
3.1 GEOMETRY 
The design of the Mg ring device began with the concept of reconnecting the two transected ends 
of the ACL using a cylindrical sheath.  To design such a device, physical dimensions were first 
calculated based on the geometry of the goat ACL (Table 1, Figure 5A).  The “working length” 
was defined as the area of the ACL that a surgeon would have access during to during a surgical 
procedure, and was limited by the depth of the femoral intercondylar notch.  The diameter and 
cross-sectional area (CSA) were expressed as a range, as these measurements increased in the 
superior-inferior direction.   
For the purposes of the Mg ring device, the ACL was approximated to be cylindrical in 
shape, an assumption supported by cross-sectional area measurements derived from a custom 
laser micrometer system 
223
 (Figure 5B).  Thus, a cylindrical design of dimensions slightly larger
than that of the native ACL was conceived. 
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Table 1: Dimensional parameters estimated from geometry of a goat ACL 
Working length/ 
height (mm) 
Diameter (mm) CSA (mm
2
)
Normal ACL 5 – 8 5 – 6.5 20 – 33 
Proposed 
dimensions 
of the Mg 
ring 
5 – 6 6 – 7 28 – 38 
Figure 5: (A) Geometry and working length of the goat ACL, (B) Cross-sectional shape as measured by a 
custom laser micrometer system 
3.2 DEVICE DESIGN AND SUTURE TECHNIQUE 
During the iterative design process of the Mg ring, three evaluative criteria were 
established for to select a design for subsequent testing.  In order to be considered successful, 
each of the following criteria must be met:  
1. Manufacturing of the device from pure Mg or Mg alloys must be possible.
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2. The device must be feasibly implanted in a goat stifle joint by an orthopaedic
surgeon without unreasonable difficulty.
3. Implantation of the Mg ring, henceforth called “Mg ring repair,” must bring the
two ends of a transected goat ACL together in tension and load the ACL.
Manufacturing of all device designs was successfully achieved in the University of 
Pittsburgh’s Bioengineering Machine Shop, in fulfillment of Criterion 1.  To produce the 
devices, the inner and outer diameters were first turned using a lathe, and then surface holes and 
other features were added using CNC milling with a custom-made mandrill.  Mg alloy AZ31 was 
used for prototype production due to its commercial availability. 
The initial design of the Mg ring (Prototype 1) is shown in Figure 6.  It was cylindrical in 
shape, with an inner diameter of 6 mm, height of 6 mm, and wall thickness of 0.25 mm.  It also 
had 8 holes of 1 mm diameter around the top and bottom of the device, such that it could be 
sutured to the two ends of a surgically transected goal ACL.   
Figure 6: Prototypes of the Mg ring 
1 2 3
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During preliminary implantations in cadaveric goat stifle joints, it was quickly discerned 
that Prototype 1 did not satisfy Criteria 2 and 3.  It was challenging to pass a ½ circle suture 
needle through a hole, into the ACL tissue, and out of an opposite hole.  Additionally, 
implantation could only be achieved by removing much of the tissue surrounding the ACL, 
including the patella, and Mg ring repair using this design did not restore tension to the ACL, as 
demonstrated by a large gap between the two transected ends.  
For Prototype 2, these shortcomings were addressed by replacing the suture holes with 4 
sets of equally-spaced notches around the top and bottom of the device, corresponding to the 
anterior, posterior, medial, and lateral sides of the ACL (Figure 6).  To implant this device, 4 sets 
of sutures were first attached to each of the transected ends of the ACL.  The ring was then 
threaded on by passing the sutures through opposite sides of the ring.  Finally, it was tensioned 
and fixed in place by pulling the sutures and tying them around the ring, with knots held within 
the notches. 
This design was able to meet Criterion 2, as it could be applied to repair the transected 
ACL with relative ease.  However, it failed at Criterion 3, as it was not possible to maintain 
sufficient suture tension while tying the sutures around the ring to bring the ends of the ACL 
together and load it in tension. 
After the failure of Prototypes 1 and 2, a different strategy was employed to ensure 
loading of the ACL.  Inspired by previous studies of mechanical augmentation of a transected 
ACL 
64, 65, 68
, bone tunnels in the femur were employed to apply greater tension to sutures used to
repair the ACL.  The Mg ring design was then modified from Prototype 2 to accommodate these 
sutures, and the final design, Prototype 3, was developed (Figure 6).   
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For surgical implantation of Prototype 3, four 1.5 mm bone tunnels were first drilled in 
the femur and tibia, with two passing anterior to the ACL’s femoral insertion site and two 
passing medial and lateral to its tibial insertion site.  Then, two sets each of “repair sutures” and 
“fixation sutures” were attached to each end of the transected ACL (Figure 7A).  The ring was 
then attached to the ACL, with the repair sutures passing directly through the ring and tied 
around it with the knots held within the set of notches.  The fixation sutures were passed through 
the suture holes from the inside to the outside, then through the bone tunnels.  They were fixed 
on the outside of the bones using a knot tied over an Endobutton on the femoral side (Smith & 
Nephew, Andover, MA) and a double-spiked plate and fixation post on the tibial side (Smith & 
Nephew) (Figure 7B).  Originally, an Endobutton was also used for tibial fixation of the Mg ring, 
but preliminary work in cadaveric goat stifle joints indicated that the use of the double-spiked 
plate resulted in improved joint stability, as it permitted control of the tension applied to the 
fixation sutures.  This also allowed for a prescribed, repeatable tension to be applied to the 
fixation sutures during Mg ring repair during each surgical procedure, resulting in greater 
consistency between tested specimen. 
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Figure 7: Procedural details for Mg ring repair, depicting attachment of repair and fixation sutures to the 
ACL (A), followed by attachment and fixation of the ring (B) 
Resorbable sutures were selected for the repair sutures.  Monofilament poly (p-
diaxanone) sutures were used initially (PDS #0, Ethicon, Inc., Bridgewater, NJ), but these were 
later replaced by braided lactide/glycolide sutures (Vicryl 2-0, Ethicon) due to their improved 
ease of use for knot tying.   Nonresorbable sutures were selected for the load-bearing fixation 
sutures to prolong the mechanical augmentation of the ACL and to remove the additional 
variable of suture degradation in in vivo applications.  Preliminary testing revealed that stronger 
sutures (Fiberwire #5, Arthrex, Naples, FL) were too large (~1 mm diameter) and led to cutting 
of the ACL tissue, while weaker sutures (Ethibond Excel #1, Ethicon) occasionally broke during 
implantation and were not able to restore stability to the stifle joint.  Thus, an intermediate suture 
was selected to successfully overcome these limitations (Ethibond Excel #2, Ethicon).  This 
polyester suture has adequate mechanical properties when quadrupled for Mg ring repair 
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(stiffness of one suture strand: 13 ± 2 N/mm; ultimate load: 134 ± 9 N) as well as a polybutylate 
coating to facilitate knot-tying for femoral fixation 
154
.
With the successful design and fabrication of the Mg ring, as well as demonstration of its 
ability to be implanted in the cadaveric goat stifle joint to bridge the gap between the two ends of 
a transected ACL, the criteria for a successful Mg ring design were met.  Thus, the goals of 
Specific Aim 1.1 were achieved.   
3.3 FINITE ELEMENT ANALYSIS 
3.3.1 Background 
To provide mechanical augmentation to the Mg ring-repaired ACL, the purpose of the Mg ring 
was to sustain forces comparable to those in the normal ACL immediately after implantation in 
the goat stifle joint.  Over time, as the device degraded and the healing ACL strengthened, this 
loading would be transferred to the ACL.  But due to repeated loading of the device and in vivo 
degradation, it would be possible for premature fracture to occur, resulting in fragmentation of 
the device, compromise of its function, and potentially complications to the animal.  Indeed, 
during preliminary experiments following Mg ring repair of the ACL, it was noted that the ring 
could experience plastic deformation or even fracture during testing.  We thus sought to address 
the research question of whether modifying the device design or Mg material could reduce the 
potential for device fracture.  In order to select a suitable design for further in vitro and in vivo 
testing, a parametric finite element model was developed.   
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3.3.2 Model development 
For the parametric analysis, 18 geometrical models were prepared in Solidworks (Solidworks 
Corporation, Waltham, MA) corresponding to variations in the Mg ring design.  4 parameters of 
interest were used, namely the wall thickness, suture hole diameter, and notch depth (Table 2).  
For these models, the outer diameter of the ring, the notch width, and the midpoint of the suture 
hole were kept constant.  Following fabrication of preliminary prototypes, it was empirically 
determined that wall thicknesses of 0.25 mm and 1 mm would not be suitable for the Mg ring, as 
0.25 mm thick rings were too easily deformable, while 1 mm thick rings were found to be too 
bulky for the goat stifle joint.  Thus, these models were eliminated, and the only the 6 models 
with a wall thickness of 0.5 mm were used in the finite element analysis.  
In addition to consideration of the Mg ring geometry, to study the additional effects of the 
composition of the ring, mechanical properties of “low,” “medium,” and “high” strength Mg 
alloys were defined.  For each, values for Young’s Modulus, yield strength, and failure strength 
were defined based on a database in the Engineering Research Center for Revolutionizing 
Metallic Biomaterials (unpublished; Table 3).  The low strength alloy was modeled after a 99.9% 
purity Mg rod, and the medium and high strength alloys were modeled after two Mg-Ca alloys 
with enhanced mechanical properties.  Thus, a total of 18 models were assessed. 
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Table 2: Designs of the Mg ring used in the parametric finite element analysis 
Table 3: Mechanical properties of Mg alloys for finite element models 
Yield Strength 
(Mpa) 
Ultimate 
Strength (Mpa) 
Young's 
Modulus (GPa) 
Alloy 
Strength 
Low 129 222 35 
Medium 293 317 42 
High 335 411 52 
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To develop the finite element model, the loading of the Mg ring was divided into three 
categories: compression when the joint was weight-bearing, fixation suture tension, and contact 
of the Mg ring with the medial and lateral sides of the femoral intercondylar notch.   
Figure 8: Illustration of 3 predicted types of in-situ loading of the Mg ring 
To model these loads, the 3-dimensional (3D) geometry of the goat stifle joint was first 
prepared.  This geometry was reconstructed from a computed tomography (CT) scan of a 
cadaveric joint (FIDEX, Animage, Pleasanton, CA).  Images from the CT scan were converted to 
an STL format using open-source software (3D Slicer, Boston, MA) and processed to remove 
surface background noise and surface irregularities (Geomagic, 3D Systems, Rock Hill, SC).  
The patella was also removed from the model, and the femur and tibia were separated to produce 
the final bone model (Figure 9). 
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Figure 9: Initial rendering (A) and final 3-D model (B) of the goat stifle joint 
Originally, it was intuitively presumed that a major mechanism of loading on the Mg ring 
was from compression as the ring was pushed into the femoral intercondylar notch when the 
stifle joint was in a weight-bearing state.  However, a preliminary finite element analysis 
revealed that there was sufficient space in the intercondylar notch such that the ring would not be 
loaded in compression, even if direct contact were to be made between the femur and tibia 
(Figure 10).  Given these findings and to simplify the model, the geometry of the bones was 
removed and the ring was subsequently modeled alone. 
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Figure 10: Schematic diagram illustrating that the Mg ring could not be driven into the femoral 
intercondylar notch by axial compression 
The Mg ring geometry was imported into ANSYS Workbench 15.0 (ANSYS, 
Canonsburg, PA) using a static structural model.  In order to perform the analysis, appropriate 
boundary conditions were required to constrain the device to prevent rigid body motion when it 
was loaded.  To do this, a conical frustum geometry of the same inner diameter as the ring was 
modeled inside it using ANSYS Design Modeler, with the top and bottom faces fixed rigidly in 
place.  It should be noted that this was not intended to simulate the ACL, but rather to prevent 
rigid body motion of the ring when loads were applied.  The contacting surfaces of the ring and 
cone were bonded together, and the cone was modeled as an isotropic material (Young’s 
Modulus: 25 MPa, Poisson’s ratio: 0.4) with properties such that it would not contribute to the 
resulting stress on the Mg ring or prevent its deformation under loading.  A mesh was then 
generated over each component, with a total of 40,000-50,000 elements and 140,000-150,000 
nodes. 
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Figure 11: The Mg ring in Ansys software modeled with a cone of the same inner diameter to constrain the 
device from rigid body motion under loading 
After removing the compressive loading, the two remaining types of loading described in 
Figure 8 were applied to the ring to simulate its in-situ loading.  The main mechanism of loading 
of the Mg ring was tension of the fixation sutures that were attached to the transected ends of the 
ACL and passed from the inside of the ring to the outside through the suture holes.  This was 
modeled by a combination of (A) a 40-N tensile load and (B) a 20-N load normal to the surface 
of the Mg ring.  The total magnitude of this load was 45 N per suture hole, or 90 N total per side 
of the ring.  This was selected as the highest in-situ load carried by the Mg ring-repaired ACL 
during testing using a robotic/UFS testing system under a 67-N anterior tibial load with 100 N 
axial compression.  The load was applied as a nodal load to the cluster of nodes on the outer 
surface of the ring (2 mm wide) that would be in contact with the fixation sutures (Figure 12). 
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Figure 12: Directions of loading in the finite element model simulating tension from fixation sutures with a 
40 N tensile load (left) and 20 N load normal to the surface of the Mg ring (right) 
To simulate loads on the Mg ring due to contact with the femoral intercondylar notch, 
additional nodal forces were applied to the medial and lateral faces of the device.  As these loads 
would be anticipated to be minor relative to the fixation suture loads, they were estimated to be 
approximately one-tenth of the magnitude (10 N) (Figure 13). 
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Figure 13: Medial and lateral loads applied to the Mg ring (A= anterior, P= posterior) 
The output of interest was the maximum Von Mises stress, which expresses the complex 
stress state of a body in a single scalar number.  This criterion is used often in finite element 
analyses as a comparison to the yield and failure strength of a material to predict whether it can 
withstand a loading condition.  For each model, the maximum Von Mises stress and its location 
on the device, as well as the stress distribution were recorded and compared to the yield and 
failure stress of the material.   
3.3.3 Finite element analysis results 
Following the simulated loading conditions, the resulting maximum Von Mises stress in each Mg 
ring design is shown in Table 4.  The corresponding stress distributions for each model are 
depicted in Figure 14.  As the stress distributions for each model were similar for all 3 alloy 
strengths, one representative image of the front and side are presented.   
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In all cases, the points of maximum stress occurred at the outer edges of the suture holes, 
which was expected as this would be the point of contact of the ring with the load-bearing 
fixation sutures.  At this point, the maximum Von Mises stress exceeded the yield stress in all 6 
designs using the low strength alloy, and exceeded the failure stress in the 2 designs with the 2.5 
mm diameter suture holes.  Due to the results from preliminary testing that led us to believe that 
the notches were also a point of weakness in the ring design, the maximum Von Mises stress on 
the longitudinal line between the notches was also recorded.  The yield stress was not reached at 
this point in any of the tested simulations. 
As expected, for each design, as the strength of the alloy increased, the maximum Von 
Mises stress also increased.  However, the material properties had a relatively small effect on the 
maximum Von Mises stress, as the difference between the maximum stress in the low and high 
strength alloys was 9 – 19 MPa.  As noted previously, the stress concentrations appeared nearly 
indistinguishable between alloy strengths.  Thus, the mechanical properties of the alloy did not 
have a large impact on the Von Mises stress. 
In contrast, variations in the surface features led to significant differences in both the 
maximum Von Mises stress as well as the stress distributions on the surface of the device.  With 
increasing suture holes diameter, the maximum Von Mises stress increased in a range from 17 – 
89 MPa.  This finding could be explained by the corresponding stress distributions, which 
showed more concentrated areas of high stress in the models as the suture hole diameter 
increased (indicated by areas of green, yellow, and red in the diagram), while other areas 
experienced little stress (blue).  Alternatively, with smaller suture holes, more moderate Von 
Mises stresses were found to be distributed more evenly throughout the surface of the device. 
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As prediced, increasing the depth of the notches also had a considerable effect on both 
the maximum Von Mises stress at the notches as well as the stress concentrations.  Increasing the 
notch depth led to increases in the maximum Von Mises stress at the notches of up to 44 MPa in 
otherwise equivalent models.  In fact, in one model (2.5 mm diameter ring, low strength alloy), 
Von Mises stress at the suture holes exceeded the yield stress of the material. Similar to the 
findings on the suture hole diameter, these results could also be explained by the stress 
distribution diagrams, which revealed high stress concentrations at the deeper notches, while 
areas around the notch sustained minimal stress.  In contrast, with the shallow notches, lower 
stress levels were distributed more evenly on the surface of the ring.  In terms of the maximum 
Von Mises stress on the device at the suture holes, there was not a clear pattern between shallow 
versus deep notches, as increases from 5 – 60 MPa were found in the 1.5 mm and 2.5 mm 
diameter suture hole models, respectively, while decreases of 11 – 15 MPa were found in the 2 
mm diameter model. 
Table 4: Resulting Von Mises stress from the parametric finite element analysis of the Mg ring (* indicates a 
value that has exceeded the yield stress; 
#
 indicates a value that has exceeded the failure stress) 
Suture hole diameter 
1.5 mm 2 mm 2.5 mm 
Alloy 
Strength 
Maximum 
at suture 
holes 
Maximum 
at 
notches 
Maximum 
at suture 
holes 
Maximum 
at 
notches 
Maximum 
at suture 
holes 
Maximum 
at 
notches 
Shallow 
notches 
Low 144.9* 77.6 192.2* 98.6 240.8
#
125.2 
Medium 147.0 83.3 197.7 103.2 247.7 128.0 
High 149.3 86.4 203.5 109.9 255.0 136.3 
Deep 
notches 
Low 150.7* 118.4 181.6* 118.3 258.7
#
136.4* 
Medium 154.8 124.1 183.9 125.7 267.6 144.4 
High 159.1 130.3 188.2 133.3 277.1 156.3 
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Figure 14: Results on the Von Mises stress distributions for the parametric finite element analysis of the Mg 
ring 
In summary, results of the parametric finite element analysis suggested that a majority of 
Mg ring models and alloys would be suitable based on the minimum success criteria of not 
exceeding the failure stress of the material under the simulated loading conditions.  The 
exception to this would be the models with 2.5 mm diameter suture holes using a low strength 
alloy.  In all models, the low strength Mg alloy exceeded the yield load, indicating that plastic 
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deformation would occur.  Overall, while the alloy strength did not greatly impact the maximum 
Von Mises stress in the ring, changes in the surface features, including the suture hole diameter 
and notch depth, led to substantial changes in the maximum Von Mises stress and stress 
distributions.  Specifically, larger surface features (increased suture hole diameter and deeper 
notches) led to increases in both of these parameters. 
The final selection of an Mg ring design suitable for further testing was made based on of 
the model results combined with surgical considerations.  First, the ring models with deeper 
notches were eliminated due to the increased stress concentrations that were found between the 
notches.  Empirically, it was confirmed that the notch depth did not affect the successful 
implantation of the Mg ring devices.  Considering only the 3 designs with shallow notches, the 
design with 2.5 mm diameter suture holes was also eliminated, as the larger suture holes also led 
to increased maximum Von Mises stress and areas of high stress concentrations.   With two 
designs remaining, production of physical prototypes of each revealed that implantation of the 
Mg ring was significantly less challenging using the ring design with 2 mm diameter sutures 
holes compared to 1.5 mm diameter holes.  Thus, this design was selected as the most suitable 
design for further in vitro and in vivo applications. 
For the material selection, although the maximum Von Mises stress was similar between 
low and high strength Mg alloys, their behavior in vivo would clearly differ, with higher strength 
alloys sustaining significantly higher loading prior to yielding or failure.  However, some plastic 
deformation of the Mg ring in vivo could actually be beneficial, as it could allow the Mg ring to 
deform to the patient-specific geometry of the femoral intercondylar notch.  This deformation 
could even prevent damage to the articular cartilage or other structures in the knee.  But with the 
complex in vivo loading conditions, combined with the changing properties of the ring as it 
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degraded, the present finite element model would be unable to select the “best” Mg material.   In 
vivo studies at a variety of time points would be required to accurately characterize and assess 
the performance of different Mg materials.   
Nevertheless, the finite element developed in Specific Aim 1.2 was successful in 
allowing for the selection of a preferred Mg ring design for further testing, as well as providing 
insight into the stress levels and distributions it may be subject to in vivo.  The model also 
indicated that alloys over a wide range of mechanical properties could be suitable for the Mg 
ring.  These results gave us confidence in our selection of a ring design for further in vitro and in 
vivo testing in Specific Aims 2 and 3. 
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4.0 IN VITRO ROBOTIC/UFS EVALUATION OF MG RING REPAIR OF THE ACL 
4.1 EXPERIMENTAL DESIGN 
To evaluate the potential application of the Mg ring device for ACL repair, experiments were 
performed in Specific Aim 2 to address the following research question: could the use of this 
device to repair the ACL (“Mg ring repair”) restore joint function and the in-situ forces in the 
ACL to normal levels immediately after implantation using our established goat model 
3, 170
 ?  To
answer this question, a robotic/UFS testing system 
136
 was employed to quantitatively evaluate
the function of cadaveric goat stifle joints following Mg ring repair when external loads were 
applied mimicking those used in clinical examinations.  Additionally, the in-situ forces in the 
medial meniscus were also measured, as studies have found significant increases in loading of 
the medial meniscus in the ACL-deficient knee 
12, 169
 and injuries to the medial meniscus are
common following ACL injury 
50
.
Fresh-frozen stifle joints from Boer goats were used.  A total of 8 joints was determined 
to be the required sample size by an a priori power analysis using previous data to determine 
differences of 2 mm in stifle joint kinematics and 10 N in in-situ forces in the ACL.  Intact stifle 
joints were thawed 24 hours prior to testing and prepared for testing as previously described 
3, 142
.
Briefly, the femur and tibia were cut 10-20 cm from the joint line, dissected free of soft tissue 
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around the joint, and potted in cylindrical molds using a fiberglass reinforced body filler 
(Everglass, Evercoat, Cincinnati, OH).     
4.2 ROBOTIC TESTING PROCEDURE 
The robotic/UFS testing system used in Specific Aim 2 was developed in our research center 
more than 20 years ago to improve upon previous methodologies to study joint function, 
including the linkage system 
95, 99
.  The UFS system (Model 4015, JR3, Inc., Woodland, CA) can
measure 3-dimensional forces and moments in a Cartesian coordinate system with a repeatability 
of 3.5 N for force and 0.35 N-m for torque, while the robotic manipulator (Puma Model 762, 
Unimate, Inc., Pittsburgh, PA) has a position and orientation repeatability of 0.2 mm and 0.2°, 
respectively.  This system can be operated in force control mode to measure the 6-DOF joint 
kinematics under externally applied loads.  It can also be used in position control mode to repeat 
previously-recorded kinematics such that the in-situ forces in joint structures can be determined 
3, 65, 136, 177, 230
.  
The potted femur and tibia were bolted to the robotic/UFS testing system and secured 
within custom clamps, with the femur fixed in a rigid pedestal base and the tibia attached to the 
end effector of the robot  (Figure 15).  An anatomical coordinate system describing the position 
of the joint relative to the UFS was defined using the position of the femoral insertions of the 
MCL and LCL relative to the end effector of the robot 
137
.  The subsequent testing procedure is
summarized in Table 5.  First, the passive path of flexion-extension was found from full 
extension to 90° of flexion, to be used as a reference position throughout testing to move 
between joint flexion angles.  This was found by moving the joint in 1° increments and finding 
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the position where forces and moments were minimized for each angle.  Next, the robotic/UFS 
testing system was operated in force-control mode to determine the stifle joint kinematics in 
response to externally applied loads simulating those used clinically to test for ACL function: (1) 
a 67-N anterior tibial load, and (2) a 67-N anterior tibial load with 100 N axial compression 
65, 94, 
129
.  Each loading condition was applied at 3 preselected angles of joint flexion (30°, 60°, and 
90°), while the robot recorded the resulting 5-DOF kinematics. 
Table 5: Experimental protocol and data obtained using the robotic/UFS testing system under a 67-N 
anterior tibial load without (I-III.A) and with (I-III.B) 100 N axial compression 
Protocol Data Obtained 
I. Intact Joint
Path of passive flexion-extension
External loading conditions
A. 67-N anterior tibial load Intact kinematics (I.A) 
B. 67-N anterior tibial load + Intact kinematics (I.B) 
100 N axial compression
Transect ACL
II. ACL-deficient joint
Repeat kinematics I.A., I.B. In-situ forces in the ACL 
Apply loads I.A, I.B ACL-deficient kinematics (II.A, II.B) 
III. Mg ring repair of the ACL
Perform Mg ring repair
Apply loads I.A, I.B. Mg ring repair kinematics (III.A, III.B) 
Release Mg ring
Repeat kinematics III.A, III.B In-situ forces in Mg ring-repaired ACL 
IV. Medial meniscus-deficient joint
Repeat kinematics I, II, III In-situ forces in the medial meniscus 
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Figure 15: Photograph of the testing set-up for Specific Aim 2, depicting the cadaveric goat stifle joint (A), 
universal force-moment sensor (B), and robotic manipulator (C) 
Next, the ACL was transected through its midsubstance using a medial parapatellar 
incision.  The previously-recorded kinematics of the joint with an intact ACL were then repeated, 
while the UFS recorded new forces and moments.  The in-situ forces in the intact ACL could 
then be determined in response to each of the loading conditions using the principle of 
superposition.  The ACL-deficient kinematics were also recorded using loading conditions (1) 
and (2).   
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Then, Mg ring repair of the ACL was performed as described in Section 3.2.  Once 
complete, the kinematics of the repaired joint were obtained using loading conditions (1) and (2).  
Finally, the ring was then removed and the previously-recorded kinematics were repeated to 
obtain the in-situ forces in the Mg ring-repaired ACL.   
To measure the in-situ forces in the medial meniscus under each condition, it was 
carefully removed from the joint.  The kinematics of the joint with the intact ACL, ACL-
deficient joint, and repaired joint were repeated to determine its in-situ forces in each state using 
the principle of superposition. 
For statistical analysis, a repeated measures analysis of variance (ANOVA) was 
performed at each knee flexion angle using SPSS Statistical Software (Version 21, IBM, 
Armonk, NY), with knee state used as the experimental factor.  Bonferroni post-hoc tests were 
done for pairwise comparisons, with statistical significance set at P ≤ 0.05. 
4.3 RESULTS 
The Mg ring could successfully connect the two ends of the transected ACL and provide 
mechanical augmentation to stabilize the goat stifle joint.  Data on anterior tibial translation 
(ATT) in response to an applied 67-N anterior tibial load are summarized in Table 6A.  For the 
joint with an intact ACL, the ATT was between 1.8 and 2.7 mm.  These values were similar at 
30° and 60°, but became lower at 90°.  Following ACL transection, the ATT increased to more 
than 12 mm, representing a significant increase of 5 to 7-fold (P < 0.05).  However, following 
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Mg ring repair, it was reduced to 4.3 to 5.8 mm, representing only 33-37% of those for the ACL-
deficient state (P < 0.05), but remained 2 – 3 mm higher than that of the intact joint (P < 0.05). 
The in-situ force data are detailed in Table 7A.  Under the 67-N anterior tibial load, the in-
situ force in the intact ACL was between 51 - 61 N, which was 73 – 90% of the applied load.  
Following Mg ring repair of the ACL, it was 55 - 63 N and was within ± 5 N of that in the intact 
ACL for all three joint flexion angles tested (P > 0.05).  The corresponding in-situ force in the 
medial meniscus was found to be negligibly small when the ACL was intact, but it increased 
significantly to 29 – 40 N (P < 0.05) following ACL transection.  With Mg ring repair, it was 
reduced to levels that were not statistically different from those in the joint with an intact ACL 
(P > 0.05) 
169
.
When a 100 N axial compressive load was added to the 67-N anterior tibial load, the 
ATT of the joint with an intact ACL was consistently 1 – 3 mm higher than those under the 67-N 
anterior tibial load alone (Table 6B).  Following ACL transection, the ATT increased 4 to 6-fold 
(P < 0.05).  After Mg ring repair, it was reduced by about 50% of those for the ACL-deficient 
state (P < 0.05), but remained 4 – 6 mm higher than that of the intact joint (P < 0.05). 
Due to the additional compressive load, the in-situ force in the intact ACL was 18 - 31 N 
higher than under the anterior tibial load alone (Table 7B).  Following Mg ring repair, it was 
restored to within ± 8 N of the intact ACL for all joint flexion angles tested.  The in-situ force in 
the medial meniscus with an intact ACL was unchanged with the additional compressive load at 
30° and 60°, but it increased by about 3-fold at 90° of knee flexion.  After transection of the 
ACL, it increased significantly to 57 – 88 N (P < 0.05).  Following Mg ring repair, it was again 
reduced by 74 – 85% compared to the ACL-deficient joint and was not statistically different 
from that in the joint with an intact ACL at 30
°
 (P > 0.05).
63 
Table 6: Anterior tibial translation (mean ± SD) of the goat stifle joints tested at 30°, 60°, and 90° of flexion in 
response to: (A) a 67-N anterior tibial load and (B) a 67-N anterior tibial load + 100 N axial compression 
Flexion Angle 
30° 60° 90° 
A. 67-N Anterior Tibial Load
Intact 2.5 ± 0.6 2.7 ± 0.9 1.8 ± 1.0 
ACL-deficient 15.2 ± 2.3*
#
 15.8 ± 1.7*
# 
12.4 ± 1.6*
# 
Mg ring repair 5.0 ± 1.0* 5.8 ± 1.0* 4.3 ± 1.3* 
B. 67-N Anterior Tibial Load + 100 N axial compression
Intact 3.8 ± 0.8 4.6 ± 0.7 3.3 ± 1.0 
ACL-deficient 17.4 ± 2.7*
# 
17.8 ± 2.7*
# 
13.6 ± 2.9*
# 
Mg ring repair 8.0 ± 1.4* 9.5 ± 1.6* 7.0 ± 1.6* 
* significantly different compared to the intact knee (P < 0.05)
# significantly different compared to Mg ring repair (P < 0.05)
Table 7: In-situ forces in N (mean ± SD) in the: (I) ACL and (II) medial meniscus of the goat stifle joints at 
30°, 60°, and 90° of flexion in response to (A) a 67-N anterior tibial load and (B) a 67-N anterior tibial load 
with 100 N axial compression 
I. ACL II. Medial Meniscus
Flexion Angle 30° 60° 90° 30° 60° 90° 
A. 67-N anterior tibial load
Intact joint 61 ± 8 59 ± 4 51 ± 9 5 ± 3 4 ± 2 6 ± 4 
ACL-deficient joint - - - 37 ± 16*
#
 46 ± 16*
#
 35 ± 15*
#
 
Mg ring repaired joint 62 ± 7 63 ± 7 55 ± 7 7 ± 4 8 ± 8 16 ± 9 
B. 67-N anterior tibial load +
100 N axial compression
    Intact joint 82 ± 13 91 ± 19 78 ± 33 9 ± 6 8 ± 6 22 ± 12 
    ACL-deficient joint - - - 57 ± 29*
#
 88 ± 40*
#
 85 ± 39*
#
 
    Mg ring repaired joint 74 ± 15 92 ± 22 79 ± 33 14 ± 9 26 ±13* 50 ± 21* 
* significantly different compared to the intact knee (P < 0.05)
# significantly different compared to Mg ring repair (P < 0.05)
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To further determine the efficacy of Mg ring repair in restoring stifle joint stability and 
ACL function, the data obtained were compared to those collected from an earlier time-zero 
study from our research center whereby only sutures were applied to repair a transected ACL 
(“suture repair”) 65. For suture repair, sutures were passed through the ACL stumps and through
opposite bone tunnels, with a function similar to the fixation sutures used for Mg ring repair.  
However, the type (Ethibond #1 versus Ethibond #2) and amount of suture material (2 strands 
versus 4 strands) differenced from suture repair to Mg ring repair.  Also, unlike Mg ring repair, 
the sutures for suture repair were tied over the bone tunnels on both sides, rather than utilizing 
the double-spiked plate and fixation post for tibial fixation.  We wished to compare Mg ring 
repair to suture repair because suture repair was also successfully used in vivo for ACL healing 
alongside an ECM bioscaffold 
66
; thus, this comparison would determine the differences in
mechanical augmentation between these methods that could lead to discrepancies in the in vivo 
healing responses.  To make the statistical comparison, the data on the knee kinematics and in-
situ forces in the repaired ACL and medial meniscus were normalized by values in the intact 
joint in order to reduce interspecimen variation, such that a value of 1.0 would indicate 
restoration to normal levels.  Then, independent t-tests were used to compare the data, with 
significance set at P ≤ 0.05. 
Under the 67-N anterior tibial load, the normalized ATT after Mg ring repair ranged from 
2.1 – 2.9 at the tested flexion angles, while for suture repair it was more than twice that and 
ranged from 5.3 – 6.2 (P < 0.05; Figure 16A).  The corresponding normalized in-situ force in the 
ACL following Mg ring repair was similar to that in that intact joint and was between 1.0 – 1.1, 
which was significantly higher than 0.6 – 0.8 following suture repair (P < 0.05; Figure 17-I.A).  
This lower in-situ force in the ACL was concomitant with a significantly higher in-situ force in 
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the medial meniscus following suture repair compared to Mg ring repair (4.7 – 13.3 and 1.8 – 
4.4, respectively; P < 0.05; Figure 17-II.A). 
With the addition of 100 N axial compression, the differences between Mg ring repair 
and suture repair were more pronounced.  Again, the normalized ATT after suture repair was 
more than two times higher than after Mg ring repair at the tested flexion angles (4.6 – 5.5 and 
2.1 – 2.2, respectively; P < 0.05; Figure 16B).  However, the in-situ force in the ACL following 
suture repair was reduced by more than 50% to just 0.1 – 0.3.  This resulted in increases in in-
situ force in the medial meniscus of up to 35 times that in the joint with the intact ACL.  In 
contrast, after Mg ring repair, the in-situ force in the ACL was maintained at 0.9 – 1.0 (P < 0.05; 
Figure 17-I.B), and the normalized in-situ force in the medial meniscus was 2.0 – 4.5 (P < 0.05; 
Figure 17-II.B). 
       A.          B. 
Figure 16: Normalized anterior tibial translation of the Mg ring-repaired and suture-repaired goat stifle 
joints at 30°, 60°, and 90° of flexion under (A) a 67-N anterior tibial load and (B) a 67-N anterior tibial load 
with 100 N axial compression 
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Figure 17: Normalized in-situ forces in (I) the ACL and (II) the medial meniscus in the Mg ring-repaired and 
suture-repaired goat stifle joints at 30°, 60°, and 90° of flexion under (A) a 67-N anterior tibial load and (B) a 
67-N anterior tibial load with 100 N axial compression
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5.0 COMBINED BIOLOGICAL AND MECHANICAL AUGMENTATION
FOR ACL HEALING 
5.1 IN VITRO CELL CULTURE STUDIES 
5.1.1 Background 
For a bioresorbable medical device, the effects of the degrading implant and its corrosion 
products on the surrounding tissues and cells are an important consideration, as they could elicit 
a harmful, neutral, or positive response in the body.  The most important requirement for the Mg 
ring would be the absence of cytotoxic effects as it degraded, as the device itself must not be 
detrimental to ACL healing.  Since the biocompatibility of Mg has been well-established, such 
effects were not anticipated to occur in vivo.  However, recent studies in other orthopaedic as 
well as cardiovascular applications have indicated that Mg may actually have a positive effect on 
cell proliferation and function 
131, 171, 214, 220, 233
; thus, the Mg ring may elicit either a neutral or
positive response on ACL healing.   
In its in vivo application, the Mg ring was intended to be used solely as mechanical 
augmentation in combination with biological augmentation using an ECM bioscaffold to 
modulate the healing response.  The underlying assumption was that any enhancement of the 
healing response would be due to the ECM treatment.  However, if Mg had a therapeutic effect 
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on ACL fibroblasts, it may also contribute to healing.  Without knowledge of the extent of these 
effects, we would not be able to discern whether the in vivo healing response was modulated by 
ECM alone, or the combination of ECM and Mg.  For this reason, prior to performing the in vivo 
study, we wished to use in vitro method to address the research question of whether Mg 
materials elicited a positive response on the growth or function of goat ACL fibroblasts. 
There are many in vitro methods that have been used to assess cytocompatibility and 
biocompatibility of Mg materials, including the live/dead assay, MTT cell viability assay, cell 
proliferation assays, and other experiments designed to assess cell function.  The International 
Standard Organization (ISO) has also issued a standard for the biological evaluation of medical 
devices that discusses the preparation of fluid “extracts” that can be used in such experiments to 
determine biological reactivity.  This standard was utilized in Specific Aim 3.1 to assess the 
cytocompatibility of 5 Mg materials, namely single crystal Mg, AZ31, ZJ40, ZJ41, and Mg-Ca-
Zr (Figure 18). 
Figure 18: Mg materials selected for in vitro testing in Specific Aim 3.1 
The Mg materials used in this Aim were chosen specifically for their clinical relevance 
and previous pre-clinical use as a biomaterial for orthopaedic applications.  The first material 
selected was single crystal Mg, provided by our collaborators in Dr. Vesselin Shanov’s 
laboratory at the University of Cincinnati.  We hoped to use this novel material for a future in 
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vivo application due to its advantageous properties.  Specifically, with its lack of grain 
boundaries, single crystal Mg possessed a high ductility that could be beneficial for the Mg ring 
by allowing it to deform without fracture.  With this lack of grain boundaries and the high purity 
of single crystal Mg, it would likely sustain slower and more even corrosion than other forms of 
pure Mg, thus preventing early fracture of the Mg ring device.  In addition, with no alloying 
elements, its clinical relevance would be high.  Next, three novel Mg alloys were selected, 
provided by our collaborators in Dr. Prashant Kumta’s laboratory at the University of Pittsburgh.  
ZJ40 and ZJ41 were Mg-Zn-Sr-Zr alloys that were used as a represent of the multitude of Mg-Zn 
alloys currently being studied for biomedical applications.  With its known biocompatibility and 
improvements to mechanical and corrosion properties, Mg-Zn alloys show much promise for 
these applications 
98, 250
.  P13 was a novel Mg-Ca-Zr alloy that was chosen as a representation of
Mg-Ca alloys, which have also been a popular choice for biomedical applications due to the 
known biocompatibility of Ca and its positive effects on device corrosion 
59
.  The addition of Zr
allows for grain refinement of these alloys, as well as a concomitant improvement in corrosion 
properties 
98
.  Finally, a commercial alloy (AZ31) was selected.  This was an aluminum-zinc
alloy that has been widely studied in vitro and in vivo, largely due to its adequate mechanical 
properties and slow corrosion rate 
121
, as well as its ease of availability.  Although the presence
of Al would not be clinically attractive due to the linkage between Al and neuron damage, 
dementia, and Alzheimer’s disease 240, this alloy was selected as a benchmark by which to assess
the novel Mg materials.   
According to EN ISO 10993-5:1999, cytotoxicity is measured via cell death, inhibition of 
cell growth, cell proliferation, or colony-forming ability.  75% cell viability is considered to be 
non-cytotoxic.  Thus, a tetrazolium salt-based assay (3-(4,5-dimethyl-2-thia-zolyl)-2,5-diphenyl-
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2H-tetrazolium bromide, or MTT) was initially chosen to assess viability of goat ACL fibroblasts 
in response to extracts from the Mg materials.  However, preliminary results in our laboratory as 
well as published literature showed that this assay is heavily influenced by Mg ion release and 
increases in pH that occur as a result of Mg corrosion.  This leads to inflated optical density 
values that reflect a false positive 
63, 173
.  Additionally, even if it were suitable for use with Mg
extracts, the MTT assay functions by assessing metabolic activity in cells and would not be able 
to differentiate between a cytotoxic (causing cell death) or cytostatic (reduced metabolic activity) 
effect. 
For these reasons, to determine the effects of Mg on cell growth, a cell proliferation assay 
(Click-It EdU, Life Technologies, Grand Island, NY) was performed at 3 days of culture.  To 
also assess cell function, the total soluble collagen in the cell culture media was measured 
(Sircol, Biocolor Life Science Assays, Carrickfergus, UK).  Soluble collagen was used due to the 
relatively short culture period, after which the majority of collagen produced would be expected 
to be released into the cell culture media. 
5.1.2 Experimental Methods 
5.1.2.1 Preparation of extracts from Mg materials 
Rods of single crystal Mg, ZJ40, ZJ41, P13, and AZ31 were machined into cylindrical discs of 5 
mm diameter x 5 mm height.  The discs were stored in ethanol prior to use, after which they 
were air-dried and sterilized using ultraviolet radiation for 1 hour.  The samples were then placed 
into modified Eagle’s medium alpha (αMEM, Life Technologies, Grand Island, NY) 
supplemented with 2% FBS and 1% penicillin/streptomycin (P/S) at 37
o
 C, with a weight-to-
extraction medium ratio of 0.2 g ml
-1
.  This ratio was selected in accordance with ISO standard
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10993:12 
196
.  Extracts were incubated for 3 days, after which the Mg discs were removed from
the cell culture media. 
Serial dilutions were prepared for each extract using αMEM supplemented with 2% FBS 
and 1% P/S and to make 50%, 25%, 12.5%, and 6% extract solutions.  100% extract was not 
used due to findings from preliminary experiments as well as previous literature that indicated a 
harmful effect on cells, possibly due to osmotic shock 
45
.  The pH of each extract concentration
was read using pH test strips.  Additionally, the osmolality of all extract dilutions from all 
materials was measured using an osmometer (Advanced Model 3320 Micro-Osmometer, 
Advanced Instruments, Inc., Norwood, MA).  Duplicate measurements of osmolality were 
recorded and averaged for each sample. 
5.1.2.2 Cell culture methods 
A primary line of ACL fibroblasts was harvested from skeletally mature female goats during 
another study requiring removal of the ACL.  The ACL tissue was minced and incubated in 
Dulbecco’s modified Eagle media (DMEM) with 1% penicillin/streptomycin, 10% FBS, and 1 
μg ml-1 collagenase for 2 hours.  The solution was then centrifuged at 2,000 RPM for 15 minutes,
and the supernatant was discarded.  The precipitated cell pellet was resuspended in DMEM with 
10% FBS.  Passage 3 (p3) cells were used for all experiments. 
5.1.2.3 Cell proliferation assay 
Goat ACL fibroblasts were cultured in αMEM with 10% FBS and 1% P/S at 37° C in a 
humidified atmosphere with 5% CO2.  At the third passage, they were seeded in 96-well cell 
culture plates, with 5 x 10
3
 cells/200 μl media in each well.  Following incubation for 24 hours
for cell attachment, the cell culture media was then replaced with 200 μl Mg extract and 
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incubated for 3 days.  Due to variability in data observed in preliminary experiments, 5 samples 
were used per Mg extract dilution.  αMEM with 2% FBS (0% extract) served as a control. 
The Click-It EdU microplate assay (Life Technologies, Grand Island, NY) was then 
performed per manufacturer’s instructions to measure cell proliferation.   This assay utilizes a 
nucleoside analog of thymidine (5-ethynyl-2’-deoxyuridine) that is incorporated into newly-
synthesized DNA with a fluorescent label (Amplex UltraRed dye).  This undergoes a “click” 
reaction with Oregon Green 488 azide.  First, a 10 μM solution of EdU was prepared and 10 μl 
was added to each well.  The samples were placed on a rotary shaker for 2 min to ensure 
adequate mixing, and were then incubated overnight (~16 hours).  The media was then removed 
and 50 μl of a fixative solution was added to each well and incubated for 5 min.  The remainder 
of the assay steps were performed in a dark environment to prevent loss of the fluorescent signal 
due to photo-bleaching.  50 μl of a reaction cocktail containing Oregon Green 488 azide was 
added to each well and incubated for 25 min.  Sample wells were then washed with a blocking 
buffer, and 50 μl of an anti-Oregon Green HRP conjugate was added to each and incubated for 
30 min.  Another wash was performed using Amplex UltraRed buffer, and 100 μl of Amplex 
UltraRed was added to each well and incubated for 15 min.  Finally, 10 μl of a stop reagent was 
added to each well and fluorescence was read using a microplate reader (Infinite M200, Tecan, 
Morrisville, NC) set at 495/519 nm for excitation and emission, respectively. 
For data analysis, measurements of fluorescence representing cell proliferation (relative 
fluorescence units, or RFU) were averaged between each set of 5 samples, and proliferation was 
expressed as a percentage of the control group (αMEM with 2% FBS, 1% P/S).  A 2-way 
ANOVA was used for statistical comparisons using SPSS Statistics (Version 21, IBM, Armonk, 
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NY), with extract percentage and Mg material as experimental factors.  Significance was set a P 
≤ 0.05, and Bonferroni post-hoc tests were performed for pairwise comparisons. 
5.1.2.4 Collagen production assay 
Goat ACL fibroblasts were cultured in αMEM with 10% FBS and 1% P/S at 37° C in a 
humidified atmosphere with 5% CO2.  At the third passage, they were seeded in a 6-well cell 
culture plates, with 4 x 10
5
 cells/2 ml media in each well.  After incubation for 24 hours for cell
attachment, the media was replaced with 2 ml Mg extract and incubated for 3 days.  αMEM with 
2% FBS (0% extract) served as a control. 
The Sircol collagen assay (Biocolor Life Science Assays, Carrickfergus, UK) was then 
performed as per manufacturer’s instructions.  This is a colorimetric assay that is designed to 
quantify collagen using a dye-binding mechanism of side chains in Sirius Red dye to those in 
collagen molecules.  First, three 100 μl samples were collected from the cell culture media of 
each extract dilution.  Reference standards of the same volume were also prepared using a stock 
solution of 500 g ml-1 soluble bovine skin collagen in 0.5 M acetic acid.  1 ml of the dye
reagent (Sirius Red in picric acid) was added to each sample and standard, and they were placed 
on a mechanical shaker for 30 min.  Samples were then placed in a microcentrifuge for 10 min at 
12,000 rpm, and the excess dye was removed.  An acid-salt wash was used to remove excess dye 
from the collagen pellet, and pellets were resuspended in 250 μl of 0.5 M sodium hydroxide.  
Finally, 200 μl of each sample was added to a 96-well plate, and the absorbance was read using a 
microplate reader (Infinite M200, Tecan, Morrisville, NC) set at 555 nm. 
For data analysis, a standard reference curve was first generated by fitting a linear curve 
to the absorbance values from the prepared standards.  The linear equation generated was then 
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used to calculate the collagen content of each 100 μl sample.  Each value was then normalized by 
the average value in the 0% extract group to represent a percentage of the control.   
A 2-way ANOVA was used for statistical comparisons using SPSS Statistics (Version 21, 
IBM, Armonk, NY), with extract percentage and Mg material as experimental factors. 
Significance was set a P ≤ 0.05, and Bonferroni post-hoc tests were performed for pairwise 
comparisons. 
5.1.3 Results 
Following incubation in αMEM for 3 days, all Mg disc samples showed visible signs of 
corrosion, and there were small amounts of particulate Mg present in the cell culture media.  The 
extracts derived from AZ31, ZJ40, and ZJ41 had become clear in color, whereas the extracts 
prepared from P13 and single crystal Mg maintained the original color of the cell culture media.  
The resulting extracts showed small increases in pH of up to 1 pH unit in the highest dilution of 
extract (Table 8).  By 3 days of culture, the pH had decreased by as much as 0.5 pH unit. 
Table 8: Initial (left) and final (right) pH values of Mg extracts 
Extract Concentration (%) 
0 6 12.5 25 50 
AZ31 8 7.5 8 8 8.5 8 8.5 8 8.5 8.5 
Single crystal 8 7.5 8.5 7.5 8.5 8 8.5 8 8.5 8.5 
ZJ40 8 7.5 8.5 8 9 8 9 8 9 8.5 
ZJ41 8 7.5 8.5 8 8.5 8 8.5 8 9 8.5 
P13 8 8 8.5 8 8.5 8 8.5 8.5 8.5 8.5 
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The osmolality of the extract dilutions is shown in Figure 19.  The osmolality of the cell 
culture media alone ranged from 300 – 307 mOsm kg-1, and for all materials there was a linear
relationship between the Mg extract concentration and osmolality.  At 50% extract, ZJ40 had the 
highest osmolality (484 mOsm kg
-1
), followed by AZ31 (427 mOsm kg
-1
).  Single crystal, ZJ41,
and Mg-Ca-Zr all had similar osmolality (357 mOsm kg
-1
).
Figure 19: Osmolality (mOsm/kg) of Mg extract dilutions 
When viewed under light microscopy, cells in the control and treated groups appeared to 
be healthy, with a characteristic spindle-shaped morphology.  No signs of apoptosis were 
observed in any of the groups.  In general, there were not visible differences between cells 
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cultured with different extract concentrations.  However, in extracts from ZJ40 and ZJ41, the 
cells appeared larger and less densely packed when cultured with 50% extract.   
The resulting cell proliferation of ACL fibroblasts when cultured with single crystal 
extracts is shown in Figure 20.  With the addition of 6%, 12.5%, 25%, and 50% extract, the cell 
proliferation ranged from 89 – 137% at the tested extract concentrations and was not statistically 
different from that of the 0% control group (P > 0.05).  The same pattern was observed for the 
other materials (Figure 21).   In facts, results of the 2-way ANOVA indicated that there were no 
statistically significant main effects of either Mg material (P = 0.175) or extract concentration (P 
= 0.284) on cell proliferation. 
Figure 20: Resulting proliferation (% of control) of goat ACL fibroblasts after 3 days of culture with extracts 
prepared from single crystal Mg (mean ± SD) 
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Figure 21: Resulting proliferation (% of control) of goat ACL fibroblasts after 3 days of culture with extracts 
prepared from Mg materials (mean ± SD) 
The resulting collagen production of ACL fibroblasts when cultured with single crystal 
Mg extracts is shown in Figure 22.  From 0 – 50% extract, there was a steady decrease in total 
collagen produced by 3 days of culture.  Upon the addition of 6%, 12.5%, 25%, and 50% extract, 
collagen production decreased by 19%, 10%, 21%, and 7%, respectively, representing 81%, 
73%, 58%, and 54% of the collagen produced by the control.  In fact, at 12.5%, 25%, and 50% 
extract, the collagen produced was significantly reduced compared to the control group, and by 
50% extract, the average collagen produced was close to half of that of the control (P < 0.05).   
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Figure 22: Soluble collagen produced (% of controls) by goat ACL fibroblasts after 3 days of culture with 
extracts prepared from single crystal Mg (mean ± SD)  (* indicates a statistically significant difference) 
When the other Mg materials were assessed, consistent patterns were observed (Figure 
23).  Both the ZJ40 and ZJ41 groups displayed a similar gradual decrease in collagen production 
with increasing extract concentration, although the ZJ41 group consistently produced 10% or 
more collagen than the ZJ40 group.  The Mg-Ca-Zr alloy group was the only one to show an 
increase in collagen with a higher extract concentration, with an increase of almost one-fifth 
from 6% to 12.5% extract (77% to 90% collagen).  However, this increase was not statistically 
significant (P > 0.05), and subsequent higher extract concentrations resulted in the same 
downward trend.  Interestingly, the AZ31 group was 40% or more lower than all of the other Mg 
materials at 6% extract, with 47% collagen produced compared to the control group (P < 0.05).  
However, this group showed a more gradual decrease at higher concentration, such that by 50% 
extract it was not significantly different from the other Mg materials (P > 0.05).  Overall, at the 
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50% extract concentration, all of the Mg material groups produced 36 – 56% of the collagen of 
the control group. 
Figure 23: Soluble collagen produced (% of control) by goat ACL fibroblasts after 3 days of culture with 
extracts prepared from Mg materials (mean ± SD)  (* indicates a statistically significant difference, # 
indicates statistical difference from all other materials) 
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5.2 IN VIVO ACL HEALING STUDY 
5.2.1 Experimental Methods 
5.2.1.1 Animal model 
Skeletally-mature (4 – 6 years of age), female Spanish goats were used for Specific Aim 3.2.  
This animal model has a large size and robust activity level that makes it well-suited for studies 
of the knee.  Additionally, the goat has been successfully used in our research center and others 
for studies of ACL reconstruction and healing 
3, 60, 66, 141, 158, 170
.
5.2.1.2 Preparation of Mg ring devices 
For in vivo experiments, single crystal Mg was used to produce the Mg ring devices.  These 
crystals of pure (99.95%) Mg were produced at the University of Cincinnati (courtesy of Dr. V. 
Shanov) using the Bridgman technique.  Briefly, polycrystalline Mg slugs (Alfa Aesar, Ward 
Hill, MA) were melted at 780 – 800o C inside a graphite crucible housed in a sealed quartz
cylindrical housing with a seed crystal on one end.  The crucible was translated at a speed of 30 
mm/hour towards a cooler region of the furnace, where crystal growth at the seed crystal began 
once the solidification temperature of Mg was reached.  During the growth process, an inert 
argon environment at an ambient pressure of 720 Torr was maintained.  X-ray diffraction was 
used to characterize the crystals to verify that a monocrystalline structure had been produced. 
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Figure 24: A single crystal of Mg produced using the Bridgman technique (courtesy of Dr. V. Shanov) 
The finished cylindrical crystals (> 8 mm diameter, > 30 mm length) were machined into 
the Mg ring geometry at the University of Pittsburgh’s Bioengineering Machine Shop using the 
methods described in Section 3.2.  Finally, to protect against corrosion, the crystals were coated 
with a ceramic oxidation coating in Dr. Yeoheung Yun’s laboratory at North Carolina 
Agricultural and Technical Institute.  Briefly, micro-arc oxidation treatment was applied by 
immersing the Mg rings attached to copper wires in electrolytic solution and applying pulse 
waveforms.  The oxidation process resulted in a < 20 μm thick oxidation coating, which could be 
observed macroscopically as an opaque white layer (Figure 25).  Following the application of the 
MAO coating, Mg ring devices were sterilized for surgery using ethylene oxide. 
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Figure 25: Single crystal Mg rings before (left) and after coating via micro-arc oxidation (right) 
5.2.1.3 Preparation of ECM bioscaffolds 
ECM sheets and pre-gel digests derived from the porcine urinary bladder matrix (UBM) were 
provided by our collaborators in Dr. Stephen Badylak’s laboratory.  Although previous work in 
our laboratory had utilized ECM from the porcine small intestine submucosa (SIS) for healing of 
the ACL as well as other ligaments and tendons 
66, 115, 132, 133
, published studies as well as
preliminary data from our research center indicated that there was not a significant difference 
between SIS and UBM in terms of the growth factors, collagen, and glycosaminoglycan content, 
nor the surface morphology of hydrogels.  Thus, due to its greater interest in clinical applications 
in orthopaedics, UBM was selected for the present study. 
Well-established protocols were used to prepare the bioscaffolds from urinary bladders of 
market-weight pigs obtained from a local abattoir 
73
.  Briefly, the bladders were first cut open
and the urothelial, serosal, and muscular layers were scraped away.  The remaining tissue 
(basement membrane and tunica propria) was treated with a 0.1% peracetic acid/ 4% ethanol 
solution and then lyophilized.  5 x 40 mm sheets were cut and sterilized with ethylene oxide. 
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To prepare the UBM hydrogels, additional lyophilized UBM was powdered using a 
Wiley Mill and filtered through a 40 mesh screen 
74, 81
.  Then, the UBM powder was 
enzymatically digested under continuous stirring using 1 mg ml
-1
 pepsin in 0.01 N HCl for 72
hours, and the resulting pre-gel digest (10 mg ECM ml
-1
 dry weight) was frozen at -20
o
 C.  On
the day of surgery, the pre-gel digest was thawed in 2.5 ml aliquots during the operation, and 
neutralized by adding one-tenth the volume of 0.1 N NaOH, one-ninth the volume of 10X PBS, 
and then diluting to a final concentration of 6 mg ml
-1
 using 1X PBS.  The hydrogel was then
passed through a sterile filter and stored on ice until injection in vivo. 
5.2.1.4 Surgical procedure 
The surgical protocol used in this study was approved by the University of Pittsburgh’s 
Institutional Animal Care and Use Committee, and procedures were performed with sterile 
techniques using general endotracheal anesthesia.  In all animals, Mg ring repair was performed 
on the right stifle joint, while the left served as a sham-operated control. 
A longitudinal incision was first made on the midline of the stifle joint from 1-2 cm 
above the patella to just below the tibial insertion of the patellar tendon.  An arthrotomy was then 
performed medially to the patellar tendon, such that the patellar tendon could be retracted 
laterally and the ACL exposed.  With clear visualization of the ACL, four bone tunnels were 
drilled in the femur and tibia using a 1.5 mm guide wire.  On the tibial side, tunnels were made 
medial and lateral to the ACL’s enthesis, while on the femoral side, two parallel tunnels were 
made anterior to the enthesis.  Mg ring repair was then performed as described in Section 3.2.  
Before fixation sutures were secured in place outside of the bone tunnels, a 5 x 40 mm UBM 
sheet sutured to a similarly-sized fibrin sponge (Surgifoam, Ethicon, Inc., Bridgewater, NJ) was 
wrapped around the Mg ring.  After fixation of the ring, additional UBM hydrogel 
66, 74, 159
 (~4
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ml) was injected directly into the injury site using an 18-gauge needle 
66
.  A local analgesic
(Bupivacaine, 1 mg kg
-1
) was injected subcutaneously for local pain management, and wounds
were closed using sutures. 
5.2.1.5 Post-operative care 
Following surgery, animals were allowed free cage activity.  For pain management, 
Banamine was administered twice daily subcutaneously (1.1 mg kg
-1
) for 5 days post-surgery, 
and Metacam was administered every 3-5 days subsequently as deemed necessary by the site 
veterinarian.  Animals were assessed daily for general health and the weight-bearing status of the 
treated joint.  A scale was used for qualitative assessment of lameness (Table 9). 
Table 9: Lameness scoring scale 
Score Weight-bearing status 
0 Three-legged walking 
1 Clear walking lameness/toe-touching 
2 Mild walking lameness, clear during running 
3 Minimal running lameness 
4 Normal 
At the end point of the study, animals were humanely euthanized.  They were first 
sedated using an intramuscular injection of Ketamine/Xylazine (7 mg kg
-1
 Ketamine, 0.1 mg kg
-1
Xylazine), followed by a lethal injection of sodium pentobarbital (1 ml (390 mg)/ 10 lbs).  Both 
treated and sham-operated legs were harvested using a scalpel by disarticulation of the hip joint. 
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A time point of 6 weeks was selected for a pilot study to preliminarily assess the proof of 
concept of the novel approach for ACL healing early in the healing process before proceeding 
with a longer study.  For the goats sacrificed at 6 weeks (N = 2), stifle joints were used for 
histology (N =1) and analysis of degradation of the Mg ring using microcomputed tomography 
(micro-CT; N = 1).  A time point of 12 weeks was selected as previous studies of the healing of 
ligaments and tendons in goats have demonstrated substantial healing by this time 
2, 66, 158
.  For
the goats sacrificed at 12 weeks (N = 7), stifle joints were used for histology (N = 1) and 
biomechanical testing (N = 6).   
5.2.1.6 Gross morphology 
The gross morphology of the healing ACL was assessed following dissection of the FATC.  The 
size, shape, color, alignment, and continuity of the healing tissue were recorded.  The cross-
sectional area and shape of the ACL were measured quantitatively using a laser micrometer 
system developed in our research center 
149, 223
, which can take non-contact measurements of
cross-sectional area (CSA) with an accuracy of ± 5%.  Measurement of the CSA was only taken 
in the 12-week group due to the presence of the Mg ring in the 6-week group that could not be 
separated from the healing tissue.  The value reported was an average of two measurements 
taken at different points near the midsubstance of the ACL.  
The articulating surface of the patella and the femoral condyles were inspected for the 
presence of osteochrondral lesions, and the fusion of the bone tunnels was assessed by the ability 
of the fixation sutures to slide freely through.     
Degradation of the Mg ring was assessed using the qualitative scale shown in Table 10.  
If Mg fragments were observed in the joint space, their size and location were also recorded.  
Finally, the presence of the fibrin sponge and ECM sheet were also noted. 
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Table 10: Qualitative scale describing degradation of the Mg ring 
Score Condition of the Mg Ring 
0 Mg ring appeared to have fully degraded 
1 Few Mg fragments observed 
2 Many large Mg fragments observed 
3 Mg ring was mostly intact 
5.2.1.7 Histological evaluation 
In the stifle joints designated for histological evaluation, the FATCs were dissected and trimmed 
immediately after harvest.  They were submerged in 10% neutral-buffered formalin (Sigma 
Aldrich, St. Louis, MO) for 48 hours and then stored in 70% ethanol prior to use. 
Histology was performed at Alizee Pathology, LLC (Thurmont, MD).  Due to the 
challenges presented by sectioning through the Mg ring to prepare the histological slide, 
methylmethacralate (MMA) was required for embedding of the healing FATC.  As a control, the 
contralateral sham-operated FATC was also evaluated, and was embedded in an oversized 
paraffin block after decalcification.  All samples were then sectioned once longitudinally and 
twice serially, and stained with hematoxylin and eosin (H&E).  They were evaluated using light 
microscopy. 
5.2.1.8 In vivo degradation of the Mg ring  
To quantitatively assess the in vivo degradation of the Mg ring, micro-CT scans were used.  This 
analysis was only performed at 6 weeks of healing (N = 1) as the degradation of the Mg ring by 
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12 weeks was very substantial and the device had degraded or fragments had migrated away 
from the ACL. 
Immediately after sacrifice, the healing FATC was dissected and trimmed, then 
submerged in 10% neutral-buffered formalin for 48 hours and stored in 70% ethanol prior to use.  
It was dried in 100% ethanol and embedded in epoxy resin, and imaged using a Skyscan 1172 
scanner (Skyscan-Bruker, Kontich, Belgium) using 10 um voxel size, 60 KVp energy, 400 ms 
exposure, and 6 exposures averaged per lateral view to reduce noise.  An offset mode was 
required as the specimen was larger than the available field of view for the desired 
magnification.  The total scan time was 12 hours. 
Reconstruction of raw files into the 3D volume was done using Skyscan ReCon software 
(Skyscan-Bruker, Kontich, Belgium), and processing for quantitative analysis of the remaining 
volume of Mg was performed using Skyscan DataViewer and CTAn software.  From 2D cross-
sectional slices in the superior-inferior direction, regions of interest could be defined manually 
surrounding the degrading Mg ring (Figure 26).  With each slice, a corresponding histogram was 
generated representing the voxel mineral densities within the region of interest.  Within the 
histogram, peaks were identified representing the surrounding bone, intact Mg, and Mg 
degradation products.  Thus, the region of interest was segmented using the inflection point 
between each of the peaks.  By then summing the voxels from each micro-CT slice, the total 
volume of intact Mg as well as the Mg degradation products could be determined.  These 
volumes were expressed as a percentage of the total initial volume of the Mg ring to represent 
the degradation of the Mg ring.  
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Figure 26: Cross-sectional slice of the degrading Mg ring from micro-CT scan (A), with manually-selected 
region of interest surrounding the Mg ring depicted in black and intact Mg depicted in white (B) 
5.2.1.9 Analysis of synovial fluid 
1 ml samples of synovial fluid were collected from treated and sham stifle joints immediately 
after sacrifice using an 18-gauge needle.  This analysis was only performed in the 12-week 
group.  A small amount (~100-200 μl) of each sample was used to smear on a glass slide, and the 
JorVet Dip Quick Stain (Jorgensen Laboratories, Inc., Loveland, CO) was used to qualitatively 
assess cytology.  After air-drying the prepared slide, it was dipped into methanol for fixation, 
followed by polychromatic stains (eosin and thiazine) to allow detection and visualization of 
nucleic acids, protein eosinophil granules, and mast cell and basophil granules.  Once prepared, 
the slides were observed under a light microscope.  The total protein content was measured using 
a refractometer. 
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5.2.1.10 Biomechanical testing 
Specimen designated for biomechanical testing (N = 6) were immediately sealed in plastic bags 
and frozen at -20
o
 C following euthanasia.  24 hours prior to testing, specimen were thawed and
prepared for testing as described in Section 4.1.  During specimen preparation as well as 
throughout biomechanical testing, a 0.9% saline solution was periodically spritzed on the sample 
to prevent dehydration. 
The joints were attached to the robotic/UFS testing system as described in Section 4.2.  In 
this Aim, a new, high-payload system was used for the measurement of joint stability and ACL 
function (Figure 27).  The UFS system (Model Theta, ATI Industrial Automation, Apex, NC) has 
a capacity of 1,500 N and 240 N-m, as well as a repeatability of 0.5 N and 0.05 N-m for force 
and torque, respectively.  The robotic manipulator (KUKA Model KR 210, Kuka Robotics Corp, 
Shelby Township, MI) has a position and orientation repeatability of less than 0.1 mm and 0.1°. 
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Figure 27: A schematic illustrating a joint being tested on the robotic/UFS testing system at preselected angles 
of joint flexion, providing 5-DOF joint kinematics (AP – anterior-posterior, FE – flexion-extension, IE – 
internal-external, ML – medial-lateral, PD – proximal-distal, VV – varus-valgus) 
In Specific Aim 3.2, force control of the robotic/UFS testing system was employed to 
measure the resulting 5-DOF stifle joint kinematics in response to a single loading condition: a 
67-N anterior-posterior tibial load, at 30°, 60°, and 90° of joint flexion.  The anterior-posterior
tibial translation (APTT) was measured and recorded as a measure of stifle joint stability.  For 
this Aim, the measurement of the posterior tibial translation was included for two reasons.  First, 
due to the reduced stability of the healing stifle joint, the robotic/UFS testing system may not 
have chosen the true neutral position, as multiple positions could be selected that would be below 
the desired force and moment threshold.  Secondly, the stifle joint center of rotation may have 
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shifted forward or backward during the healing process.  Measurement of APTT would be able 
to correct for these changes. 
Once the kinematics under the 67-N anterior-posterior tibial load were recorded, they 
were repeated as each of the following knee structures was removed: MCL, soft tissue and LCL, 
medial meniscus, lateral meniscus, PCL, and bony contact.  The corresponding in-situ force in 
each structure in the joint was calculated using the principle of superposition, and the final set of 
forces measured with only the FATC represented the in-situ force in the ACL. 
After testing on the robotic/UFS testing system, uniaxial tensile testing was performed to 
determine the structural properties of the FATC.  Each FATC was mounted to a materials testing 
machine (Model 4052, Instron, Canton, MA) using custom clamps such that the ACL was 
aligned anatomically in its natural direction of tensile loading (Figure 28).  It was then preloaded 
to 3 N, and the gauge length was reset.  It was then cyclically preconditioned between 0 – 1 mm 
of elongation, which was in the toe region of the load-elongation curve, for 10 cycles at a 
crosshead speed of 50 mm min
-1
.  Finally, the 3 N preload was reapplied, and the FATC was
loaded to failure at a crosshead speed of 10 mm min
-1
.  From the resulting long-elongation curve,
the structural properties of the FATC were determined, including the stiffness, ultimate load, and 
ultimate elongation. 
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Figure 28: The FATC mounted on the materials testing machine for uniaxial tensile testing 
5.2.1.11 Data analysis 
All statistical analysis was performed using SPSS Statistics (Version 21, IBM, Armonk, NY), 
with statistical significance set at P ≤ 0.05.  Data representing the cross-sectional area, total 
protein content of the stifle joint synovial fluid, joint kinematics, in-situ forces, and tensile 
properties were compared using two-tailed paired t-tests.  For the data on joint kinematics and in-
situ forces, statistical analyses were performed separately for data at each joint flexion angle. 
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5.2.2 Results 
All goats recovered well from surgery and were mobile and able to bear weight on the treated 
joints within 1-2 hours post-operatively.  By day 17, most were able to walk with a small limp 
that was more pronounced during running (lameness score ≥ 2), and by day 45, all could run 
freely with little to no limp (lameness score ≥ 3). 
During the 12-week study, three goats of an original group to 10 did not survive to the 
12-week time point due to complications not related to the experiment.  Following sacrifice at 12
weeks, one specimen was observed to have undergone a surgical error, and it was excluded from 
the study.  Another specimen was damaged by the robotic/UFS testing system and was also 
excluded.   Thus, the total sample sizes were N = 2 at 6 weeks of healing and N = 5 at 12 weeks 
of healing.   
5.2.2.1 Gross morphology of the healing ACL 
By 6 weeks, the stifle joint had minimal swelling.  The healing ACL was composed of 
translucent neo-tissue growing within and around the degrading Mg ring, in addition to slightly 
reddish, opaque tissue where the preserved ends of the ACL remained (Figure 29).  There was no 
hypertrophy of the healing ACL, and there was a small gap (< 1 mm) within the Mg ring 
between the two transected ends of the ACL.  In both specimen, the Mg ring had fractured into 3 
– 5 fragments, but these fragments appeared to have remained attached to the ACL by the
healing tissue as well as the fixation sutures.  The surface of the Mg ring was dull and dark gray 
in color.  The ECM sheet and fibrin sponge were not visible in the joint space.  
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Figure 29: Gross morphology of the healing ACL at 6 weeks 
By 12 weeks, the stifle joint was found to be stable upon manual examination and signs 
of swelling had subsided.  Observation of the gross morphology of the healing ACL revealed a 
robustly healed neo-ligament that was mostly white and opaque in color (Figure 30).  The tissue 
appeared to be well-aligned with longitudinal collagen bundles.  The geometry of the healing 
ACL also resembled that of a normal ACL, except that it was slightly more oblong in shape.  
There was a small amount of hypertrophy, as the cross-sectional areas determined by the laser 
micrometer system increased from 28.9 ± 4.0 mm
2
 in the sham-operated ACL to 37.6 ± 9.6 mm
2
in the healing ACL (Figure 31).  However, this difference was not statistically significant (P = 
0.12).  Inspection of the femoral condyles and articulating surface of the patella revealed no 
signs of degenerative osteochondral lesions or defects.   
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Figure 30: Gross morphology of the sham-operated ACL (A) and Mg ring-repaired ACL (B) 
Figure 31: Cross-sectional area and shape of the sham-operated and healing ACL 
The scores representing the condition of the Mg ring are shown in Table 11.  In two 
animals, (ear tags #761 and #765) there was no visible trace of the Mg ring, which appeared to 
have fully degraded.  In two other animals (ear tags #740 and #714), fragments (< 3 mm 
diameter) were found attached to the ACL, and some had migrated in the joint space.  The 
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fragments attached to the ACL had become encased in a small fibrous capsule that was attached 
to the ligament.  However, no cytotoxic or adverse reaction was observed.  In one animal (ear tag 
#550), the Mg ring appeared to be mostly intact, though it had fractured into 3-5 large pieces that 
were embedded mostly in the healing ACL. 
Table 11: Scores representing the degradation of the Mg ring at 12 weeks of healing 
Goat Ear Tag # Score Presence of ring fragments 
740 2 
Cluster of tiny fragments on the anterior region of the 
ACL; one large fragment adjacent to the lateral meniscus 
550 3 
Mostly intact Mg ring embedded in the healing ACL; one 
fragment adjacent to the PCL 
714 2 
Fragments embedded in the medial anterior ACL 
midsubstance and medial meniscus 
761 1 None 
765 1 None 
5.2.2.2 Histological evaluation 
The histology of the sham-operated ACL was found to be characteristic of a normal ACL.  It was 
composed of dense collagen bundles that were longitudinally aligned (Figure 32A), and was 
covered with a synovium that was 30-40 μm thick (Figure 32B). 
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Figure 32: Histology of the sham-operated ACL, depicting longitudinally-aligned collagen bundles (A) and 
normal synovium (B) (L – ligament) 
A longitudinal section of the healing FATC at 6 weeks of healing is shown in Figure 33.  
A 0.5 – 2.5 mm gap was observed between the transected ends of the ACL that was partially 
filled with granulation tissue at the proximal side of the Mg ring.  Within this tissue were some 
macrophages, a few foreign body giant cells, and rare neutrophils.  Inflammation observed in the 
granulation tissue was concentrated near fixation suture material, which was a minor and 
expected foreign body response.   
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Figure 33: Histological section of the healing FATC at 6 weeks of healing using H&E staining (T= tibia, A= 
ACL, P= PCL, F= femur) 
The healing ACL enclosed within the degrading Mg ring at the same healing time point is 
shown in Figure 34A.  The Mg ring contained pits of corrosion that were lined with hyalinized 
collagen (Figure 34B), and at the interface of the ring with the ACL, there was also a minimal to 
mild inflammatory response.  Nearby the fracture site of the Mg ring and in close proximity to 
the gap observed between the transected ends, there were small amounts of crystalloid-like 
fragments of the Mg ring that were likely degradation products (Figure 34C).  These fragments 
also elicited a mild inflammatory response that was composed of macrophages and a small 
number of lymphocytes.  Around the majority of the healing ACL, there was a morphologically 
normal synovium.  This synovium was not observed around the tissue within the Mg ring, which 
was likely due to the adhesion of this tissue to the inside surface of the Mg ring (Figure 34D). 
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Figure 34: Histological image of the Mg ring–repaired ACL (A), pitting corrosion lined with hyalinized 
collagen (B), small degrading fragments of the Mg ring (C), and lack of normal synovium around ACL tissue 
adhered to inner surface of the Mg ring (D) (G= granulation tissue, M= Mg ring, C= collagen) 
The histological appearance of the healing ACL at 12 weeks is shown in Figure 35.  
Whereas at 6 weeks the two ends of the transected ACL could be clearly distinguished, by 12 
weeks of healing the healing ACL had become continuous, with some visible alignment of its 
collagen fibers.  Small fragments of Mg were also observed to be embedded in the healing ACL, 
but these did not appear to be detrimental to the surrounding tissue  
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Figure 35: Histological section of the healing FATC at 12 weeks of healing using H&E staining (T= tibia, A= 
ACL, F= femur; arrow indicates Mg fragment) 
5.2.2.3 Degradation of the Mg ring 
A 3D reconstruction of the degrading Mg ring at 6 weeks of healing is shown in Figure 36, with 
the ring shown in orange and the trimmed femur and tibia depicted in green.  This illustrated how 
the ring had fractured in vivo, yet retained the fragments near the ACL due to embedding in the 
healing tissue as well as attachment to fixation sutures.  Examination of this reconstruction 
indicated fracture of the Mg ring device at predicted locations: between the notches as well as 
adjacent to suture holes. 
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Figure 36: 3D rendering of the degrading Mg ring at 6 weeks of healing in the goat stifle joint with femoral 
and tibial bone blocks 
By examining the 3D slices from the micro-CT scan, pitting corrosion was found to have 
occurred throughout the device.  By then segmenting the densities of the intact and degrading 
Mg, the volume of intact Mg was found to be 21.0 mm
3
, which was 57% of the starting volume
of Mg.  The volume of degradation products was found to be 14.7 mm
2
.  If it is assumed that
there was no change in volume as intact Mg became degradation products, these values can be 
combined to be 35.7 mm
3
, which would indicate that 98% of the original Mg was still present in
the ACL. 
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5.2.2.4 Cytology and total protein content of synovial fluid 
The synovial fluid in the sham-operated joints was clear and slightly yellow in color and was 
very viscous.  Due to sparse quantities, manipulation of the needle and the joint was required 
during sample collection such that sufficient fluid could be retrieved.  In contrast, the synovial 
fluid in the healing stifle joint was slightly reddish in color and was less viscous.  A larger 
quantity was also present, such that sample collection could be easily achieved without 
manipulating the needle or joint. 
When the stained slide was viewed under light microscope, the cytology of the synovial 
fluid from the sham-operated and healing ACL was found to be similar.  In both groups, there 
was low cellularity, with few synovial cells and red blood cells in a lacy matrix.  In the treated 
group, there were a few more synovial cells, as well as a few lymphocytes and macrophages.  
There were no signs of infection or an abnormal inflammatory response. 
The total protein content in the synovial fluid from the sham-operated joints was 2.6 ± 
0.2 g dl
-1
, which was similar to the value of 2.4 g dl
-1
 estimated for normal joint synovial fluid in
goats (one-third of the total blood serum protein content) (Figure 37) 
10
.  The total protein
content in the synovial fluid from the healing joints was 3.4 ± 0.5 g dl
-1
, and was significantly
higher (P = 0.02).  However, the values remained below the threshold of 4.5 g dl
-1
 above which
significant inflammation has previously been reported 
1
.
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Figure 37: Total protein content in synovial fluid from sham-operated and healing goat stifle joints at 12 
weeks of healing (P < 0.05) 
5.2.2.5 Joint stability and in-situ forces 
The curves representing the average APTT in the sham-operated and Mg ring-repaired joints are 
shown in Figure 38.  As the patterns were similar at all tested joint flexion angles, results at 60° 
of joint flexion are shown for illustrative purposes.  In the graph, elongation began at the point of 
maximum posterior tibial translation and continued to the point of maximum anterior tibial 
translation.  With the PCL left intact in both groups, the posterior tibial translation in response to 
the 67-N posterior tibial load was similar between groups.  The curve for the sham-operated 
group continued with a near-linear slope through the application of the 67-N anterior tibial load.  
However, near the neutral position (~20 N posterior tibial load), the Mg ring-repaired joint 
became less stable, and began to experience higher translation with small increases in loading.  
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This continued until 10-20 N of anterior tibial loading, after which the ACL and other joint 
structures were engaged to limit subsequent translation. 
Figure 38: Average curves for the APTT in the sham-operated and Mg ring-repaired joints at 60° of stifle 
joint flexion under a 67-N anterior-posterior tibial load (mean ± standard error) 
The APTT in response to the 67-N anterior-posterior tibial load is shown in Table 12.  In 
both the sham-operated and Mg ring-repaired joints, the APTT increased from 30° to 60° of 
stifle joint flexion, then decreased at 90°.  The APTT in the sham-operated group ranged from 2 
– 5 mm, and was similar to previously-reported values for a normal goat stifle joint 3, 65, 66.  At all
tested flexion angles, the APTT in the Mg ring-repaired joint was 2 – 3 times that in the sham-
operated joint, and the differences were statistically significant at all tested flexion angles (P ≤ 
0.05). 
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The in-situ forces in the sham and Mg ring-repaired ACL in response to the 67-N anterior 
tibial load are also shown in Table 12.  The in-situ force in the ACL in the sham-operated joint 
was close to the applied load and ranged from 53 – 64 N.  The in-situ force in the Mg ring-
repaired ACL was close to that of the sham-operated ACL at 30° of flexion (P > 0.05), and 
decreased by ~20 N at 60° of flexion, but the difference compared to that in the sham-operated 
ACL was not statistically significant (P > 0.05).  At 90° of joint flexion, the in-situ force in the 
Mg ring-repaired ACL decreased again by ~20 N, and this was significantly lower than that in 
the sham-operated ACL (P < 0.05). 
Table 12: Anterior-posterior tibial translation (A) and in-situ forces in the ACL (B) of the sham-operated and 
Mg ring-repaired goat stifle joints at 30°, 60°, and 90° of joint flexion (*indicates a statistically significant 
different compared to sham-operated controls; P ≤ 0.05) 
Flexion Angle 
30° 60° 90° 
A. Anterior-posterior tibial
translation
    Sham-operated group  3.8 ± 1.5 4.0 ± 1.5 3.4 ± 1.3 
    Mg ring-repaired group 9.8 ± 2.3* 11.5 ± 1.9* 9.4 ± 1.4* 
B. In-Situ forces in the ACL
Sham-operated group 63 ± 6 64 ± 6 53 ± 4 
Mg ring-repaired group 59 ± 16 41 ± 29 19 ± 19* 
To better understand the differences between the function of the sham-operated and 
healing stifle joints, it is useful to also compare the in-situ forces in other structures in the stifle 
joint.  These forces are shown in Figure 39 for each tested joint flexion angle.  The force 
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distribution amongst joint structures differed between the groups, as well as based on the flexion 
angle.  At 30° of stifle joint flexion, the majority of the in-situ force under the 67-N anterior 
tibial load was in the ACL in both the sham-operated and healing groups.  In the sham-operated 
joints, there were also smaller forces in the lateral meniscus (~40 N) and bony contact (~20 N), 
but in the healing joints these forces shifted to the medial meniscus (~40 N).  At 60° of joint 
flexion, the majority of force in the sham-operated group was again carried by the ACL, and the 
forces carried by the lateral meniscus and bony contact decreased by half to ~20 N and 10 N, 
respectively.  In contrast, in the healing joints, the in-situ force in the ACL was decreased, with 
forces also carried by the medial meniscus (~40 N) and MCL (~20 N).  Finally, at 90° of flexion, 
the in-situ forces in the sham-operated joints were again carried mostly by the ACL, with smaller 
forces carried by the MCL, medial meniscus, and bony contact (~10 N each).  Alternatively, in 
the healing joints, the ACL carried a much smaller force (~20 N), while other joint structures 
carried equal or higher forces, including the MCL (~20 N), soft tissue (~25 N) and medial 
meniscus (~30 N). 
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A. 
B. 
C. 
Figure 39: In-situ forces in the MCL, soft tissue, medial meniscus, lateral meniscus, bony contact, and ACL in 
the sham-operated and Mg ring-repaired goat stifle joints at 30° (A), 60° (B), and 90° (C) of joint flexion 
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5.2.2.6 Tensile properties 
The load-elongation curves for the sham-operated and healing FATCs followed the expected 
trend for a ligament, beginning with a toe region of low stiffness for the first 1-1.5 mm of 
elongation, followed by a linear region of greater stiffness prior to failure.  All of the healing 
ACLs failed in the midsubstance of the tissue.  
The structural properties of the FATC are shown in Table 13.  Two of the four specimen 
had distinctly higher structural properties, with stiffnesses of 110 and 101 N/mm, and ultimate 
loads of 553 and 601 N.  In contrast, the other two specimen had lower properties, with 
stiffnesses of 53 and 44 N/mm and 185 and 143 N.  For all specimen, the ultimate elongation 
was similar and was between 4.5 – 6.5 mm.   
The average linear stiffness of the FATC with the healing ACL reached 60% of that of 
the sham-operated controls, but the difference was not statistically significant (P > 0.05).  The 
average ultimate load reached 35% of the sham-operated control group, and this difference was 
statistically significant (P < 0.05).  The ultimate elongation in the FATC with the healing ACL 
was approximately half that of the sham-operated control group, but the difference was not 
statistically significant (P > 0.05). 
Table 13: Structural properties of the healing and sham-operated FATCs (*indicates a statistically significant 
different compared to sham-operated controls; P ≤ 0.05) 
Healing 
Sham-
operated 
control 
Stiffness (N/m) 77 ± 33 128 ± 25 
Ultimate Load (N) 371 ± 240* 1070 ± 326 
Ultimate Elongation (mm) 5.7 ± 0.8 10.7 ± 3.3 
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5.2.2.7 Comparison to ECM treatment alone 
To further assess the advantages of ECM treatment with Mg ring repair, the cross-sectional area, 
joint kinematics, in-situ forces in the ACL, and tensile properties were compared to data 
previously collected in our laboratory using ECM alone for repair of a transected ACL at 12 
weeks of healing 
66
.  For statistical comparison, data were first normalized by the respective
value in the sham-operated controls (experimental/control, or e/c) to reduce interspecimen 
variability.  Then, independent t-tests were used to compare groups, with significance set at P ≤ 
0.05. 
All of the healing ACLs, regardless of treatment group, healed with continuous neo-tissue 
formation (Figure 40).  The cross-sectional area of the ECM-treated ACL was 127 ± 90% of the 
sham-operated control, and was similar to those in the Mg ring-treated ACL (130 ± 26%; P > 
0.05) (Figure 41).  However, while the ECM + Mg ring-treated joints had a fairly consistent area, 
the ECM-treated joints showed more variability, with one joint each that was much larger or 
smaller than the sham-operated control. 
Figure 40: Gross morphology of the healing ACL with ECM treatment + Mg ring repair (A) and ECM 
treatment alone (B) 
BA
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Figure 41: Cross-sectional area (% of control) of the ECM-treated ACL and ECM + Mg ring-repaired ACL 
The normalized APTT and in-situ forces in the healing ACL are shown in Figure 42. 
Under the 67-N anterior tibial load, the normalized APTT with ECM treatment alone ranged 
from 2.5 – 3.5 at all tested flexion angles (Figure 42A).  The normalized APTT for ECM 
treatment + Mg ring repair was similar and ranged from 2.9 – 3.2 (P > 0.05).  The corresponding 
normalized in-situ force in the ACL with ECM treatment was 0.6 – 1.0 at the tested flexion 
angles.  These values were again not statistically different compared to those with ECM 
treatment + Mg ring repair, which were 0.3 – 1.0 (P > 0.05; Figure 42B).   
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A. 
B. 
Figure 42: Normalized APTT (A) and in-situ forces in the ACL (B) in the healing goat stifle joints with ECM-
treated or ECM + Mg ring-repaired ACLs 
ECM-treated ACL ECM + Mg ring-repaired joint
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The structural properties of the healing FATCs in terms of normalized stiffness and 
ultimate load are shown in Figure 43.  The normalized stiffness in the healing FATC after ECM 
treatment + Mg ring repair was 30% higher than that with ECM treatment alone (62.7 ± 34.5% 
versus 48.1 ± 18.8%, respectively), but this difference was not statistically significant (Figure 
43A, P > 0.05).  The normalized ultimate load in the healing FATC after ECM treatment + Mg 
ring repair was 2.5 times that with ECM treatment alone (39.3 ± 33.3% versus 15.9 ± 8.5%, 
respectively), but this difference was also not statistically significant (Figure 43B, P > 0.05). 
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A. 
B. 
Figure 43: Normalized stiffness (A) and ultimate load (B) of the femur-ACL-tibia complex with the ECM-
treated and ECM + Mg ring-repaired ACL 
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6.0  DISCUSSION AND FUTURE DIRECTIONS 
In this dissertation, a novel methodology to improve the healing of a surgically transected ACL 
has been developed, using ECM bioscaffolds combined with a bioresorbable Mg ring device as 
biological and mechanical augmentation, respectively.  To do this, the geometry of the Mg ring 
was first designed based on the ACL in a cadaveric goat model.  A parametric finite element 
analysis was then used to select a Mg material and best design features such that the maximum 
Von Mises stress and stress concentrations on the device were reduced to be below failure stress 
levels.  Using the final device design, a unique surgical implantation procedure was also 
developed.  The ability of Mg ring repair to restore stifle joint stability and in-situ forces in the 
ACL and medial meniscus was then tested by means of a robotic/UFS testing system.  Under 
externally-applied loads, Mg ring repair of the ACL could restore anterior tibial translation to 
within 2 – 6 mm of those for the joint with the intact ACL, as well as in-situ forces in the ACL to 
within ± 10 N of normal.   
With these encouraging results, the potential of the Mg ring was assessed in vitro and in 
vivo by means of cell culture as well as use of the Mg ring in a live animal model.  Culture of 
goat ACL fibroblasts with serial dilutions of extracts from 5 different Mg materials was used to 
assess the resulting cell proliferation and collagen production to determine whether Mg elicited a 
therapeutic on ACL fibroblasts.  Mg extracts of up to 50% did not lead to increases in either the 
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cell proliferation nor collagen production; thus, Mg materials would not be expected to 
contribute to the healing response in vivo.   
Finally, the Mg ring was tested in vivo alongside an ECM bioscaffold from the porcine 
urinary bladder matrix for repair of a surgically transected goat ACL, and was evaluated at 6 and 
12 weeks of healing.  By 6 weeks, healing tissue had begun to fill the gap between the two ends 
of the transected ACL, and the Mg ring had begun to degrade but remained attached to the 
healing ACL.  By 12 weeks, the healing ACL was composed of robust, continuous tissue with 
aligned collagen fibers, and was similar in size and shape to that of the normal ACL.  
Biomechanically, the stifle joint stability and in-situ forces in the ACL were similar to those 
previously reported following ACL healing using ECM bioscaffolds as well as those following 
ACL reconstruction in the same animal model 
3, 66, 157, 159
.  On the other hand, the structural
properties of the femur-ACL-tibia complex following Mg ring repair were improved over both of 
those treatments.  These exciting findings suggest significant advances of Mg ring repair for 
treatment of a transected ACL. 
6.1 DISCUSSION OF THE MG RING DESIGN 
In Specific Aim 1, the primary goal was the development of a Mg ring design that was suitable 
for the studies proposed in Specific Aims 2 and 3.  First, in Specific Aim 1.1, the Mg ring was 
designed based on the geometry of the goat ACL and then fabricated from a commercially-
available Mg alloy.  In collaboration with orthopaedic surgeons, an iterative design process with 
refinement through a series of prototypes was used such that a novel device design together with 
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an implantation technique was achieved to bridge the gap between the two ends of a surgically 
transected ACL in a cadaveric goat stifle joint.  
Although Mg ring repair was based on previous strategies employed to repair an injured 
ACL 
64, 65
, the Mg ring design and suture repair technique was designed as a novel improvement
upon these strategies to give the ACL a better chance to heal.  The fixation sutures used for Mg 
ring repair restored approximately half of the stiffness of the native ACL immediately after 
surgery, while the repair sutures drew the two transected ends of the ACL back together.  The 
passage of the fixation sutures out of the suture holes could protect the ACL from abrasion with 
neo-tissue at the injury site, and helped to align the ring.  The ring itself also could serve as a 
barrier to protect the neo-tissue of the healing ACL from the synovial environment, as well as act 
as a reservoir to contain the ECM hydrogel.  Thus, the novel Mg ring design and repair technique 
had many advantages over previous methodologies to help heal a transected ACL. 
In Specific Aim 1.2, the goal was to use a finite element analysis under simulated loading 
conditions to assess the stresses and stress distributions on variations of the Mg ring design, such 
that a preferred design for subsequent testing could be selected.  Through this analysis, we found 
that the mechanical properties of the Mg ring did not have a large effect on the maximum Von 
Mises stress or stress concentrations on its surface, but modification to its geometry, including 
deepening the notches and increasing the diameter of the suture holes led to large increases in 
stress.  Based on the success criteria, the final ring design that was most suitable for repair of the 
ACL was selected. 
In summary, the findings of Specific Aim 1 provided the basis for which a Mg ring 
design and suture technique were developed to bridge the gap between the two ends of a 
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transected goat stifle joint.  The results of this Aim could then be applied directly to further in 
vitro and in vivo testing in Specific Aims 2 and 3. 
6.2 IN VITRO ROBOTIC TESTING 
In Specific Aim 2, the primary goal was to use the 6-DOF robotic/UFS testing system to test the 
stifle joint stability and ACL function after the transected ACL was repaired by the Mg ring 
device 
177, 230
.  It was hypothesized that since suture (mechanical) augmentation was successful in
restoring stifle joint stability and ACL function 
65
, the Mg ring repair of the ACL would also be
able to restore anterior tibial translation (ATT) of the Mg ring-repaired ACL and in-situ force in 
the ACL to levels close to those in the intact stifle joint and ACL, respectively.   
Indeed, we found that Mg ring repair could stabilize the cadaveric stifle joint by restoring 
its ATT to within 2 – 6 mm of those for stifle joint with an intact ACL following a 67-N anterior 
tibial load, with or without 100 N axial compression.  The corresponding in-situ forces in the 
repaired ACL were also returned to those in the joint with the intact ACL.  Thus, these findings 
confirmed our hypothesis and positively answered the research question.  In addition, Mg ring 
repair of the ACL was also able to reduce excessive loading on the medial meniscus; thus, 
lowering the potential of its injury following ACL injury 
12, 50, 169
.  The ATT and in-situ forces in
the ACL and medial meniscus were also significantly improved compared to suture repair 
65
.  In
fact, they were close to those observed in previous studies using sutures for bone-to-bone 
fixation as well as those following ACL reconstruction 
65, 68, 142
.
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The reasons for these significant improvements compared to suture repair can be 
attributed in part to the strength of the fixation sutures.  Both suture repair and Mg ring repair 
drew the two ends of the transected ACL back together by attaching sutures to each end and 
passing them through tunnels drilled in the opposite bones.  In suture repair, a single suture 
(Ethibond #1) was used for end side of the transected ACL, resulting in a total suture stiffness of 
24 N/mm.  However, in Mg ring repair, two stronger sutures (Ethibond #2) were used, resulting 
in a total suture stiffness of 52 N/mm.  With more than double the suture stiffness, Mg ring repair 
ACL could more effectively restore stability to the stifle joint as well as load the repaired ACL. 
The results on ATT in this Aim were consistently ~2 mm higher than those observed for 
a suture augmentation procedure in the same animal model 
65
.  It would not be possible to
achieve the level of stability using an ACL repair technique compared to direct bone-to-bone 
fixation without risking cutting the remaining ACL stumps using high-stiffness sutures.  
However, the ATT was restored to within 6 mm of normal and the in-situ forces in the Mg ring-
repaired ACL were returned to levels in the normal joint immediately after surgery.  Thus, it was 
hoped that Mg ring repair could provide the needed mechanical augmentation for the transected 
ACL to heal and remodel with the help of the ECM bioscaffolds.   
6.3 IMPACT OF THE IN VITRO AND IN VIVO EVALUATION OF THE MG RING 
FOR ACL HEALING 
In Specific Aim 3, we first sought to evaluate the effect of Mg on goat ACL fibroblasts using in 
vitro cell culture studies (Specific Aim 3.1).  Then, we wished to evaluate the efficacy of the Mg 
ring for ACL healing using in vivo experiments in a goat model (Specific Aim 3.2).   
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Studies on the effects of Mg extracts on goat ACL fibroblasts were performed to help to 
address the question whether Mg may enhance ACL healing in vivo.  The results would help to 
elucidate what is modulating the healing response of a transected ACL: ECM alone or ECM in 
combination with the Mg ring.  Goat ACL fibroblasts were cultured in the presence of extracts 
from 5 Mg materials ranging in concentration from 6 – 50%, and their proliferation and collagen 
production were measured.  While the Mg extracts did not affect fibroblast proliferation (P > 
0.05), significant decreases of up to 50% in collagen production were found between the highest 
extract concentration (50%) and the control group (P < 0.05), contrary to our hypothesis.  The 
fact that Mg extracts did not increase cell proliferation was in agreement with the work of 
Fischer and associates, who found no statistical differences in the proliferation of human 
osteosarcoma cells at 3 days of culture with up to 50% extract 
63
.  Some studies using 
tetrazoliom-based cytotoxicity assays have suggested that Mg extracts enhance cell viability at 
some concentrations, thus potentially eliciting a therapeutic effect 
45, 98, 130
, but it has been noted
that these assays heavily influenced by Mg ion release and increases in pH that occur as a result 
of Mg corrosion, which can generate a false positive result 
63
.  Thus, the positive effects on Mg
on cellular activity remain mostly speculative.   
The decreases observed in collagen synthesis may have been due to osmotic shock that 
was caused by the sudden increase in solute concentration when the Mg extracts were added 
62
.
Indeed, measurement of the osmolality of the solution indicated that the osmolality increased 
with increasing extract concentration, with up to 40% higher osmolality found in the 50% extract 
compared to the control.  Furthermore, increases in pH were observed compared to the control 
group in all extract solutions, which may also have contributed to the decreased production of 
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collagen.  There are other factors that may have influenced collagen production that were not 
studied, such as the ion concentration of the Mg materials and their corrosion products 
41
.
One of the most notable questions for all in vitro cytotoxicity studies of Mg is the actual 
concentration of Mg at the site of a degrading implant, and how to simulate it using an Mg 
extract dilution.  The answer to this question is multi-factorial and time-dependent, with location 
in the body and the degradation profile of the implant also playing a significant role.  According 
to the current ISO standard typically utilized for these experiments, Mg extracts of up to 100% 
may be used for cell culture experiments, which clearly cause cytotoxicity and compromise of 
cell function due to osmotic shock.  However, there is widespread belief that a ten-fold dilution 
may be a more appropriate representation of a physiological environment.  For this reason, 
extract dilutions ranging from 6 – 50% were utilized in the present experiments.  
The differences in the results on cell proliferation and collagen production were 
unexpected, and further study to fully characterize the effects of Mg extracts on ACL fibroblasts 
are warranted.  It can be speculated that the use of primary cell lines may have resulted in a 
change in cell phenotype; alternatively, the changes observed in osmolality or pH may have 
affected the ability of the cells to produce collagen 
123
.  Further, there are distinct limitations to a
static cell culture environment as a representation of a very complex in vivo environment. But as 
the primary goal of Specific Aim 3.1 was to assess the cytocompatibility of Mg materials on goat 
ACL fibroblasts and determine whether the presence of Mg would enhance the proliferation and 
collagen production of these cells, the present study did find that Mg did not elicit a positive 
response on either the cell proliferation or collagen production of goat ACL fibroblasts; thus, it is 
suggested that any enhancement of healing would most likely be a result of the application of the 
ECM bioscaffolds.   
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In Specific Aim 3.2, the in vivo model designed to assess the effectiveness of the Mg ring 
used alongside our earlier model of an ECM bioscaffold and hydrogel to heal a transected ACL 
was tested 
66
.  By 6 weeks, neo-tissue had begun to form between the transected ends of the
ACL, and by 12 weeks post-operatively, substantial healing had taken place and the neo-tissue of 
the ACL was robust and close in size and shape to that of the normal ACL.  Morphologically, it 
also showed significant improvement over those using ECM treatment alone 
66
.  This 
improvement was due to the additional mechanical augmentation provided by the Mg ring, 
which loaded the healing ACL and helped to stabilize the stifle joint and as a result, aided in the 
healing process.   
The in vivo degradation and failure appeared to differ between specimen, and by 12 
weeks, the Mg ring had resorbed partially, completely, or barely at all.  In all cases, the ring had 
fractured into multiple pieces.  Comparing the ACL healing response with the ring degradation, 
it can be observed that healing was generally better when the ring had fragmented or degraded 
away completely.  This may be because larger pieces of the ring could shift in their orientation 
and block the formation of continuous tissue between the transected ends of the ACL.  Indeed, 
the presence of small ring fragments adjacent to the ACL or elsewhere in the joint space did not 
appear to lead to complications in any of the goats.  Thus, a ring that is faster to degrade and be 
released from the ACL may be preferable for healing.   
The results on the anterior-posterior tibial translation (APTT) under the externally 
applied 67-N anterior-posterior load were elevated compared to the sham-operated controls, and 
increased compared to our time-zero findings in Specific Aim 2.  However, these findings are 
consistent with both ECM treatment alone as well as studies of ACL reconstruction in a goat 
model 
3, 49, 157
, after which elevated translations have been observed even one year after surgery.
122 
The most exciting finding was that the structural properties of the healing FATC were 
improved compared to ECM treatment alone.  The stiffness (e/c) of the FATC was 30% higher 
and ultimate load (e/c) 2.5 times higher.  These findings confirmed our hypothesis that the 
combination of biological and mechanical augmentation had enhanced ACL healing.  In 
addition, when compared to ACL reconstruction (at the same time point and in the same animal 
model), these results also compared favorably; i.e., the stiffness and the ultimate load were two 
times and 1.4 times higher, respectively 
157
.  All of these findings could have large clinical
impact on the treatment of an injured ACL, and the details will be discussed further in Section 
6.6. 
It should be noted that there was variability observed in the biomechanical data, which 
was consistent with other findings from our research center in goats 
66
 and can be expected with
animal research 
69, 150, 158
.  Two of the specimen had the most robust healing response, and the
stiffness of the FATC 101 N/mm and 110 N/mm and ultimate loads of 553 N and 600 N, 
respectively, while the other two had lower biomechanical properties that were close to those 
using ECM treatment alone 
66
.  We recognized that the level of healing may have been related to
the fixation of the sutures outside the femoral and tibial bone tunnels.  For the latter specimen, 
the sutures attaching the Endobutton appeared to be loosened and had migrated away from the 
original fixation site, and the fixation sutures could glide freely through the femoral bone tunnels 
(Figure 44).  As the Endobutton loosened, the stifle joint stability would be lost, even if the ACL 
healed.  Thus, the lack of joint stability would prevent sufficient loading of the healing ACL and 
would influence its healing capability. 
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Figure 44: Photographs illustrating sliding of the femoral fixation sutures at 12 weeks of healing in 2 
specimen, showing the gap between the Endobutton and femur before (left) and after applying tension (right) 
On the tibial end, the fixation of the double-spiked plate and fixation post was remained 
tight by 12 weeks, given that this fixation method rigidly attaches the sutures to the bone.  Thus, 
for future studies, the femoral fixation needs to be improved in order to gain more consistent 
results on improved ACL healing with superior biomechanical properties.  
6.4 IMPACT AND IMPLICATION FOR TISSUE ENGINEERING AND 
REGENERATIVE MEDICINE 
The findings of this dissertation clearly demonstrated the potential of using a combined approach 
of biological and mechanical augmentation for healing of an injured ACL.  The Mg ring repair 
together with an ECM bioscaffold will lead to a stronger ACL over those using ECM treatment 
alone as well as ACL reconstruction.  Following ACL reconstruction, there are clearly 
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unfavorable long-term results, including the early onset of osteoarthritis 
7, 27, 165
.  The majority of
ACL reconstruction patients are reasonably young, so this could have especially significant 
impact on their quality of life in the future.  Thus, successful development of an ACL healing 
approach could shift the paradigm of clinical management.  A healed ACL has a number of 
advantages and could represent a promising alternative to ACL reconstruction with better long-
term results.  Furthermore, new technologies could be extended and employed to aid in the 
healing and regeneration of other “hard to heal” ligaments and tendons, including those in the 
shoulder, elbow, and ankle.   
The newly developed Mg ring device has also provided a valuable testbed for studying 
the use of a Mg device in vivo.  As a relatively unexplored class of biomaterials, Mg and its 
alloys have not been fully characterized, and many questions remain regarding biocompatibility, 
degradation behavior, and effects on the healing response.  Prior to approval for clinical use by 
the Food and Drug Administration, rigorous benchtop as well as pre-clinical testing of Mg 
devices will be required, and the work in this dissertation can be added to the growing body of 
literature characterizing the use of Mg-based devices for a variety of healing applications. 
6.5 LIMITATIONS 
There are a number of limitations to the work described in this dissertation.  First, the advantages 
of Mg ring repair in a goat model may not be directly applicable to the human knee due to 
differences in its size, shape, range of motion, loading conditions, and so on.  However, the goat 
model has been successfully used in a number of preclinical studies involving the ACL 
3, 66, 142, 
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170, 204
, and is considered to be an acceptable animal model.  With its large size and robust 
activity level, it is one of the most suitable animal models for pre-clinical studies of the knee. 
In the design of the Mg ring in Specific Aim 1, the finite element analysis was a 
simulation of simplified and estimated loading conditions on the Mg ring that would be 
experienced in vivo.  Further, the parametric analysis was done on a small number of selected 
designs and Mg alloys, and they would need to be experimentally validated.  However, the 
model did provide a simple, standardized tool with which we could assess a number of design 
features so that the most promising for in vitro and in vivo applications in Specific Aims 2 and 3 
could be chosen.   
The loading conditions for the in vitro robotic testing in Specific Aim 2 were chosen to 
simulate those used in clinical examinations to test for ACL function, and represent average 
loads applied to the goat ACL during gait 
94
, but do not represent complex loading conditions in
a live animal.  In the future, biplanar fluoroscopy technology could be used to record 6-DOF 
joint kinematics during activities of daily living, which could then be repeated on the 
robotic/UFS testing system to determine the corresponding joint kinematics and in-situ forces in 
the ACL.  Testing using the robotic/UFS testing system also measured the passive response of 
the structures of the goat stifle joint and did not simulate the complex neural response of the 
ligaments and tendons.  Although this is an inherent limitation of this technology, the data 
obtained from this system on non-contact measurement of the in-situ forces in the ACL and other 
joint structures was extremely valuable to understanding of the contribution and function of the 
Mg ring-repaired ACL. 
Further, the ACL was transected through its midsubstance prior to Mg ring repair, which 
is not representative of ACL rupture clinically.  However, our goal was to first demonstrate the 
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feasibility of ACL repair and regeneration using the Mg ring.  Future work should include 
development of an injury model to generate a more realistic tear. 
In Specific Aim 3.1, the in vitro techniques for proliferation and collagen production of 
goat ACL fibroblasts had several limitations.  In terms of the collagen production, only soluble 
collagen was measured, as the majority of collagen was anticipated to be released into the cell 
culture media during the relatively short culture period.  However, further work to quantify 
insoluble collagen may be warranted to more accurately capture the fibroblast collagen 
production.  Overall, due to the use of static, in vitro cell culture, the data are also not directly 
representative of the in vivo conditions of those in Specific Aim 3.2, as they did not replicate the 
complex intraarticular environment, with synovial fluid, vascular and nutrient supply, 
mechanical loading, and other cell types also playing a role in modulating ACL healing. 
Furthermore, the cells used in the present experiments were normal ACL fibroblasts.  For the 
future, a dynamic cell culture system as well as the use of healing ACL fibroblasts would be 
needed to better mimic the in vivo environment.  However, the goal of this Aim was to utilize a 
simple cell culture system to elucidate whether Mg may contribute to the ACL healing process in 
vivo, and was sufficient to address our research question.   
In the in vivo experiment of Specific Aim 3.2, due to the high costs of a large animal 
model, we were limited to a final sample size of only 2 goats at 6 weeks of healing and 5 goats at 
12 weeks of healing.  Results of a power analysis indicated that more than double the sample size 
would be required adequate statistical power (β = 0.8).  Additionally, due to the costly nature of 
a large animal study, we were unable to include a control group.  For this reason, for comparative 
purposes, data from previous work using ECM treatment alone were normalized by that of the 
sham-operated control to reduce interspecimen variation and used for comparison of 
127 
biomechanical properties.  Post-operative rehabilitation of the animals was also not ideal, as 
bracing or controlled motion was not possible, and animals were generally running, jumping, and 
head-butting as shortly as a few hours after surgery.  To limit physical activity as well as 
fighting, animals were thus housed individually in a smaller enclosure for 4 – 7 days post-
surgery.  Finally, a rigorous assessment of the biology of the healing response could not be made 
in terms of specific cells and cell phenotypes or gene expression due to the lack of available 
antibodies and PCR primers in goats.  Development of new methods for such as assessment will 
be the subject of future work.  In spite of these limitations, we successfully demonstrated the 
proof of concept of ACL healing using the Mg ring device in combination with an ECM 
bioscaffold, and future work will be done to increase the sample size for statistical power as well 
as add control groups.  
6.6 FUTURE DIRECTIONS 
In this dissertation, a novel strategy on combining biological and mechanical 
augmentation to heal a surgically transected ACL was successfully executed.  Still, much work 
remains before this new approach could be ready for clinical application.  The immediate next 
step for evaluation of the Mg ring-repaired ACL would be to perform a longer-term animal study 
to assess whether Mg ring repair could prevent disuse atrophy of the ACL’s insertion sites, as 
well as further improve the biomechanical properties of the FATC.  As a control, an ACL 
reconstruction group of goats should also be included for comparison.  Such a study would allow 
for the assessment of stifle joint function, biomechanical properties of the FATC, cross-sectional 
area of the healing ACL or replacement graft, histomorphology of the healing ACL and joint 
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capsule, as well as the degenerative changes in the articular cartilage, so as to determine whether 
the Mg ring-repaired ACL may be advantageous over the current “gold standard” of treatment.  
This would need to be proven to overcome the clinical barrier impeding adoption of an 
alternative treatment option by orthopaedic surgeons.  Following the successful proof of concept 
of ACL healing using the Mg ring at multiple time points, an injury model will be developed in 
goats that is representative of an ACL tear clinically, to be used in subsequent pre-clinical 
studies.   
Of course, with the numerous strategies available for biological and mechanical 
augmentation of an injured ACL, further study of modified or alternative approaches are also 
warranted.  A schematic diagram representing further development of such an approach is shown 
in Figure 45, depicting the feedback loop between biological and mechanical augmentation 
approaches with both in vitro and in vivo experiments to optimize the ACL healing strategy. 
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Figure 45: Schematic diagram for further development of a combined biological and mechanical 
augmentation strategy to heal an injured ACL 
In terms of the biological augmentation, this work relied on an ECM sheet and hydrogel 
derived from the porcine urinary bladder matrix for ACL healing, and this and previous studies 
have shown that such an approach could lead to successful ACL healing.  However, it might be 
more advantageous to consider using other new FTE approaches, including a multi-laminate 
ECM sheet to be a better scaffold for cells as well as to better enclose the Mg ring device such 
that particulate matter from the device degradation could be kept at the site and could not migrate 
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into the joint space.  Additionally, a “pillow” composed of ECM powder enclosed within two 
ECM sheets could be designed to be inserted into the Mg ring device as an alternative to a 
hydrogel for more sustained release.  The ring itself could even assist in biological augmentation 
using new technologies such as the application of laser micro-wells to be used for the delivery of 
bioactive molecules.  Further development of methods to assess the healing response from a 
biological standpoint could also be developed to understand how ECM bioscaffolds modulates 
the healing response. 
On mechanical augmentation, consideration should be given to new and improved 
fixation sutures, including resorbable sutures of different strengths.  In the future, an expansion 
of the computational finite element analysis could also help to predict the behavior of the Mg 
ring and Mg ring-repaired ACL in vivo.  Temporal effects of repeated loading as well as 
degradation of the ring could be incorporated into the model.  These effects would also be 
important in addition to the mechanical properties of the device to predict when and how failure 
of the device would occur, and would be a useful tool in a more rigorous selection of an 
appropriate device design and Mg material.  This would be of particular importance when 
scaling the Mg ring for human application, for which device behavior could not be validated by 
in vivo studies.  In addition, incorporation of the ACL into the model would be a useful tool to 
demonstrate how loading of the Mg ring-repaired ACL is distributed between the ring and the 
ACL substance and insertion sites. 
 This finite element analysis should be done in concert with a more rigorous analysis of 
the Mg ring’s degradation in vivo.  Some variability was observed in the current study, where in 
some animals, the ring had completely degraded while in others multiple fragments remained 
embedded in the ACL.  With data on degradation rates, one can consider development of other 
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Mg materials and coatings or surface treatment to provide a consistent degradation profile that 
matches the rate of ACL healing. 
With advances in the computational modeling and the development of Mg materials and 
surface coatings, the Mg ring device design can be refined and optimized.  New and improved 
designs can be studied and evaluated in vitro and in vivo in combination with new FTE 
approaches for biological augmentation, in order to select the best combination for ACL healing. 
Following pre-clinical work, the Mg ring technology can then be scaled up for human 
application.  This would include modifications to the device itself as well as the development of 
a much simpler, arthroscopic procedure to insert the ring device and sutures on to the ruptured 
ACL.  Devices of different sizes and shapes could be designed for variations in patient body size, 
or patient-specific ring geometries could be made using 3-D printing.  If successful, the ring 
technology could also be extended as a novel alternative approach for the healing of other “hard 
to heal” injured ligaments and tendons.  With the success of such approaches, we will move 
forward towards the long-term goal of the Musculoskeletal Research Center of improving the 
management of soft tissue injuries and reducing complications; thus, leading to better patient 
outcomes and long-term quality of life. 
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